Introduction {#s1}
============

Neoblasts are planarian adult somatic stem cells that exhibit levels of plasticity and pluripotency comparable to embryonic and induced pluripotent stem cells ([@bib17]; [@bib61]; [@bib84]). In flies, fish, mice and humans, adult somatic stem cells are fate-restricted, sustaining production of cell lineage(s) in resident tissues ([@bib21]; [@bib81]). Although embryonic stem cells cultured ex vivo remain capable of producing a diversity of tissue types from different germ layers, such plasticity is typically lost from most somatic cells as development proceeds. In contrast, the planarian neoblast population is wholly responsible for the production of all differentiated cell types in these bilaterally symmetric, triploblastic animals ([@bib5]). In fact, transplantation of a single neoblast into a stem cell deficient host was sufficient for rescue and long-term reconstitution ([@bib84]), confirming the pluripotency of planarian somatic stem cells. Despite longstanding discussion of the similarities between neoblasts and embryonic stem cells, a comparison explicitly stated in the original definition of the term ([@bib57]), the provenance of neoblasts during embryogenesis was unknown.

Neoblasts are abundant and widely distributed across the anteroposterior axis, occupying the parenchymal space surrounding the gut ([@bib58]). All neoblasts contain chromatoid bodies ([@bib4]; [@bib29]; [@bib31]; [@bib46]) and express nuage genes, including *piwi-1*, and factors implicated in germ cell identity, genome surveillance and post-transcriptional regulation of gene expression ([@bib26]; [@bib52]; [@bib58]; [@bib64], [@bib65]; [@bib67]; [@bib71]; [@bib73]; [@bib83]; [@bib89]). Neoblasts are the only cycling somatic cells in adults ([@bib6]; [@bib48]; [@bib51]; [@bib66]); quiescent neoblasts were not observed in BrdU pulse chase experiments ([@bib48]). Mounting evidence suggests that the neoblast population contains pluripotent stem cells as well as cycling, lineage-primed progenitors ([@bib59]). Heterogeneous expression of developmental transcription factors (TFs) in neoblasts has been reported and likely reflects the diversity of lineage-primed progenitors within the compartment ([@bib1]; [@bib13]; [@bib14]; [@bib38], [@bib39]; [@bib43]; [@bib54]; [@bib69], [@bib70]; [@bib78]; [@bib86]).

*Schmidtea mediterranea* (*Smed*) freshwater flatworms are stable diploids that exist as two biotypes: asexual animals that reproduce by fission, and obligate cross-fertilizing hermaphrodites that reproduce sexually ([@bib49]; [@bib50]). Both biotypes mount robust regeneration responses following amputation, and similarly rely on neoblasts for homeostatic maintenance and regeneration of all tissues. The asexual clonal line CIW4 (C4) has received the most scrutiny in studies examining the molecular mechanisms underlying regeneration, neoblast maintenance, pluripotency and lineage commitment ([@bib49]). However, neoblasts are ever-present in C4 animals, precluding investigation of their developmental origin. Neither a normal table for *Smed* embryonic development nor functional studies have been reported.

Our work establishes *Smed* as a developmental model system and leverages the novel, unexploited context of embryogenesis to hone the molecular and operational definition of the planarian neoblast. We generated a molecular staging resource for *Smed* embryogenesis that associates unique gene expression signatures with chronological age, embryo morphology, representative images and written summaries of key developmental events to holistically describe and define prototypes for each stage. We also provide an atlas of molecular markers describing temporary embryonic tissue types and definitive organ system development. These data, found in the supplementary material, are also searchable online at <https://planosphere.stowers.org.>

We investigated the developmental origin of neoblasts during *Smed* embryogenesis and show that early embryonic cells are molecularly and functionally distinct from the adult neoblast population. Pluripotent neoblasts and lineage-dedicated progenitors arise as organogenesis begins. Our results suggest that the framework for understanding cell fate specification and organ formation during *Smed* embryogenesis diverges radically from existing developmental paradigms. Here, in a bilaterally symmetric, triploblastic animal not thought to undergo gastrulation ([@bib10]; [@bib40]; [@bib68]; [@bib75]), heterogeneous expression of key developmental regulators within a pluripotent, cycling blastomere population generates the panoply of lineage-dedicated progenitors required for organogenesis. Moreover, neoblasts perpetuate embryonic developmental programs during adulthood, where they are required for continued maintenance and rebuilding of tissues during homeostasis and regeneration.

Results {#s2}
=======

A molecular staging series for *Smed* embryogenesis informed by single embryo RNA-Seq {#s2-1}
-------------------------------------------------------------------------------------

*Smed* flatworms are direct developers: newborn hatchlings grow and mature into adult worms without an intervening larval stage ([@bib68]). At hatching, juveniles are sexually immature but otherwise possess a body plan grossly similar to that of adult hermaphrodites ([@bib68]; [@bib85]). *Smed* embryos undergo an evolutionarily divergent mode of development that bears little resemblance to the ancestral Spiralian cleavage programs utilized by many Lophotrochozoans. *Smed* embryos are ectolecithal: yolk is not contained within oocytes, but rather is produced by somatic vitellaria (yolk glands) arrayed ventrolaterally beneath the testes ([@bib12]; [@bib74]; [@bib75]). Oocytes are fertilized internally by sperm from a partner. Zygote(s) are packaged, along with yolk cells, into an egg capsule in the genital atrium ([Figure 1A](#fig1){ref-type="fig"}) ([@bib12]; [@bib32]; [@bib50]; [@bib75]).10.7554/eLife.21052.003Figure 1.A molecular staging series for *Smed* embryogenesis informed by single embryo RNA-Seq.(**A**) Top: Cartoon depicting the reproductive system of a sexually mature *Smed* hermaphrodite. Ventral view. G, gonopore; O, ovary; OD, oviduct; P, penis papilla; SD, sperm duct . Oocytes are fertilized internally and zygote(s) are packaged with yolk produced by vitellogenic gland cells into a developing egg capsule in the genital atrium (purple). Capsules are laid through the gonopore. Bottom: Brightfield image of a live *Smed* hermaphrodite. Anterior: left. Dorsal view. White asterisk: pharynx. (**B**) Developmental timeline and staging designations for *Smed* embryogenesis at 20°C. Timeline: days (d) post egg capsule deposition. Gray bars and letters C--I ﻿indicate time windows, and corresponding panels (C--I), for RNA-Seq samples. Double-headed arrows: time windows for stages (S) S1--S8. (**C**--**I**) Brightfield images of live embryos harvested for RNA-Seq (top), hematoxylin- and eosin-stained sections (middle), and heat maps for enriched transcripts (bottom). Scale bars: 100 µm. Yellow arrowheads: temporary embryonic pharynx. Black arrowheads: definitive pharynx. Heat maps depict cohorts of enriched transcripts at indicated stages. (**J**) Principal component analysis demonstrates clustering of replicates and separation of developmental time points in expression space. (**K**) Correlation matrix for single embryo sequencing replicates. Total transcripts with a row sum \>1 CPM: 31,248. (**C**--**K**) Y,yolk. 2, S2. 3, S3. 4, S4. 5, S5. 6, S6. 7, S7. 8, S8.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.003](10.7554/eLife.21052.003)10.7554/eLife.21052.004Figure 1---source data 1.Molecular staging resource for *Smed* embryogenesis.Tab 1 (staging overview): an overview of the molecular staging resource materials for S1--S8: developmental time interval (days post-egg capsule deposition, 20°C); names of single embryo RNA-Seq replicates; references to representative images (live brightfield and histological cross-sections); number of enriched transcripts; references to [Figure 1](#fig1){ref-type="fig"} supplement files containing mean centered expression and raw RPKM profiles across embryogenesis for enriched transcripts; references to [Figure 1](#fig1){ref-type="fig"} source data files (excel spreadsheets) containing enriched transcripts, organized by cluster membership, with RPKM profiles across development, BLASTx-based annotations, GO analysis, and short written descriptions of each stage (S2--S8). Additional tabs are included for: (1) pairwise comparison overview; (2) mixed stage reference overview; (3) lists of enriched transcripts for S2---S8, compiled from both the pairwise and mixed stage reference analysis; (4) GO triage criteria; (5) categories and lists of biological process (BP) GO IDs, manually curated from the statistically significant hits for S2--S8-enriched transcripts; (6) summary table containing the number and percentage of enriched transcripts (S2--S8) assigned to BP GO ID categories.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.004](10.7554/eLife.21052.004)10.7554/eLife.21052.005Figure 1---source data 2.Stage-2-enriched transcripts from pairwise and/or mixed stage reference comparisons.Criteria for inclusion are indicated in [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}, as well as the legends for [Figure 1---figure supplements 2](#fig1s2){ref-type="fig"}--[3](#fig1s3){ref-type="fig"}. Tabs in this excel file contain: (1) pairwise comparison data (if applicable), (2) mixed stage reference comparison data, (3) cluster membership (see [Figure 1C](#fig1){ref-type="fig"}), average RPKM values across embryogenesis (Y--S8), and in C4 and SX adults, as well as best BLASTx hits (E \< 0.001) versus the NR, Swiss-Prot, C. *elegans*, *D.* melanogaster, *D. rerio*, *X. tropicalis*, *M. musculus* and *H. sapiens* RefSeq databases, (4) GO analysis: manually curated and categorized biological process (BP) GO IDs and (5) GO analysis: unabridged results. See also [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.005](10.7554/eLife.21052.005)10.7554/eLife.21052.006Figure 1---source data 3.Stage-3-enriched transcripts from pairwise and/or mixed stage reference comparisons.Criteria for inclusion are indicated in [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}, as well as the legends for [Figure 1---figure supplements 2](#fig1s2){ref-type="fig"}--[3](#fig1s3){ref-type="fig"}. Tabs in this excel file contain: (1) pairwise comparison data (if applicable), (2) mixed stage reference comparison data, (3) cluster membership (see [Figure 1D](#fig1){ref-type="fig"}), average RPKM values across embryogenesis (Y--S8), and in C4 and SX adults, as well as best BLASTx hits (E \< 0.001) versus the NR, Swiss-Prot, *C. elegans, D. melanogaster, D. rerio, X. tropicalis, M. musculus* and *H. sapiens* RefSeq databases, (4) GO analysis: manually curated and categorized biological process (BP) GO IDs, and (5) GO analysis: unabridged results. See also [Figure 1---figure supplement 5](#fig1s5){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.006](10.7554/eLife.21052.006)10.7554/eLife.21052.007Figure 1---source data 4.Stage-4-enriched transcripts from pairwise and/or mixed stage reference comparisons.Criteria for inclusion are indicated in [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}, as well as the legends for [Figure 1---figure supplements 2](#fig1s2){ref-type="fig"}--[3](#fig1s3){ref-type="fig"}. Tabs in this excel file contain; (1) pairwise comparison data (if applicable), (2) mixed stage reference comparison data, (3) cluster membership (see [Figure 1E](#fig1){ref-type="fig"}), average RPKM values across embryogenesis (Y--S8), and in C4 and SX adults, as well as best BLASTx hits (E \< 0.001) versus the NR, Swiss-Prot, *C. elegans, D. melanogaster, D. rerio, X. tropicalis, M. musculus* and *H. sapiens* RefSeq databases, (4) GO analysis: manually curated and categorized biological process (BP) GO IDs, and (5) GO analysis: unabridged results. See also [Figure 1---figure supplement 6](#fig1s6){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.007](10.7554/eLife.21052.007)10.7554/eLife.21052.008Figure 1---source data 5.Stage-5-enriched transcripts from pairwise and/or mixed stage reference comparisons.Criteria for inclusion are indicated in [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}, as well as the legends for [Figure 1---figure supplements 2](#fig1s2){ref-type="fig"}--[3](#fig1s3){ref-type="fig"}. Tabs in this excel file contain; (1) pairwise comparison data (if applicable), (2) mixed stage reference comparison data, (3) cluster membership (see [Figure 1F](#fig1){ref-type="fig"}), average RPKM values across embryogenesis (Y--S8), and in C4 and SX adults, as well as best BLASTx hits (E \< 0.001) versus the NR, Swiss-Prot, *C. elegans, D. melanogaster, D. rerio, X. tropicalis, M. musculus* and *H. sapiens* RefSeq databases, (4) GO analysis: manually curated and categorized biological process (BP) GO IDs, and (5) GO analysis: unabridged results. See also [Figure 1---figure supplement 7](#fig1s7){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.008](10.7554/eLife.21052.008)10.7554/eLife.21052.009Figure 1---source data 6.Stage-6-enriched transcripts from pairwise and/or mixed stage reference comparisons.Criteria for inclusion are indicated in [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}, as well as the legends for [Figure 1---figure supplements 2](#fig1s2){ref-type="fig"}--[3](#fig1s3){ref-type="fig"}. Tabs in this excel file contain; (1) pairwise comparison data (if applicable), (2) mixed stage reference comparison data, (3) cluster membership (see [Figure 1G](#fig1){ref-type="fig"}), average RPKM values across embryogenesis (Y--S8), and in C4 and SX adults, as well as best BLASTx hits (E \< 0.001) versus the NR, Swiss-Prot, *C. elegans, D. melanogaster, D. rerio, X. tropicalis, M. musculus* and *H. sapiens* RefSeq databases, (4) GO analysis: manually curated and categorized biological process (BP) GO IDs, and (5) GO analysis: unabridged results. See also [Figure 1---figure supplement 8](#fig1s8){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.009](10.7554/eLife.21052.009)10.7554/eLife.21052.010Figure 1---source data 7.Stage-7-enriched transcripts from pairwise and/or mixed stage reference comparisons.Criteria for inclusion are indicated in [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}, as well as the legends for [Figure 1---figure supplements 2](#fig1s2){ref-type="fig"}--[3](#fig1s3){ref-type="fig"}. Tabs in this excel file contain; (1) pairwise comparison data (if applicable), (2) mixed stage reference comparison data, (3) cluster membership (see [Figure 1H](#fig1){ref-type="fig"}), average RPKM values across embryogenesis (Y--S8), and in C4 and SX adults, as well as best BLASTx hits (E \< 0.001) versus the NR, Swiss-Prot, *C. elegans, D. melanogaster, D. rerio, X. tropicalis, M. musculus* and *H. sapiens* RefSeq databases, (4) GO analysis: manually curated and categorized biological process (BP) GO IDs, and (5) GO analysis: unabridged results. See also [Figure 1---figure supplement 9](#fig1s9){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.010](10.7554/eLife.21052.010)10.7554/eLife.21052.011Figure 1---source data 8.Stage-8-enriched transcripts from pairwise and/or mixed stage reference comparisons.Criteria for inclusion are indicated in [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}, as well as the legends for [Figure 1---figure supplements 2](#fig1s2){ref-type="fig"}--[3](#fig1s3){ref-type="fig"}. Tabs in this excel file contain; (1) pairwise comparison data (if applicable), (2) mixed stage reference comparison data, (3) cluster membership (see [Figure 1I](#fig1){ref-type="fig"}), average RPKM values across embryogenesis (Y--S8), and in C4 and SX adults, as well as best BLASTx hits (E \< 0.001) versus the NR, SwisSchmidteas-Prot, *C. elegans, D. melanogaster, D. rerio, X. tropicalis, M. musculus* and *H. sapiens* RSeq databases, (4) GO analysis: manually curated and categorized biological process (BP) GO IDs, and (5) GO analysis: unabridged results. See also [Figure 1---figure supplement 10](#fig1s10){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.011](10.7554/eLife.21052.011)10.7554/eLife.21052.012Figure 1---source data 9.Molecular fate mapping resource.Short summaries describing molecular markers for temporary embryonic tissues and definitive organ systems. Written descriptions accompany [Figure 1---figure supplement 11](#fig1s11){ref-type="fig"} (primitive ectoderm), [Figure 1---figure supplement 12](#fig1s12){ref-type="fig"} (temporary embryonic pharynx), [Figure 1---figure supplement 13](#fig1s13){ref-type="fig"} (gut), [Figure 1---figure supplement 14](#fig1s14){ref-type="fig"} (definitive pharynx), [Figure 1---figure supplement 15](#fig1s15){ref-type="fig"} (definitive epidermis), [Figure 1---figure supplement 16](#fig1s16){ref-type="fig"} (nervous system), [Figure 1---figure supplement 17](#fig1s17){ref-type="fig"} (muscle), [Figure 1---figure supplement 18](#fig1s18){ref-type="fig"} (protonephridia) and [Figure 1---figure supplement 19](#fig1s19){ref-type="fig"} (eyes).**DOI:** [http://dx.doi.org/10.7554/eLife.21052.012](10.7554/eLife.21052.012)10.7554/eLife.21052.013Figure 1---figure supplement 1.Histological cross-sections of Stage one embryos.(**A**--**D**) Four independent examples of the single cell stage (S1), either metaphase II arrested oocytes or zygotes, in paraffin embedded, hematoxylin- and eosin-stained sectioned egg capsules fixed at 1--2 days post egg capsule deposition. The entire capsule is shown in (**D**). Black arrowheads: metaphase II arrested oocytes or zygotes, surrounded by a corona of yolk cells. Scale bars: 25 µm ([**A**]{.smallcaps}--**C**); 100 µm (**D**).**DOI:** [http://dx.doi.org/10.7554/eLife.21052.013](10.7554/eLife.21052.013)10.7554/eLife.21052.014Figure 1---figure supplement 2.MA plots for pairwise comparisons.(**A**) S2 vs Y. (**B**) S2 vs S3. (**C**) S3 vs S4. (**D**) S4 vs S5. (**E**) S5 vs S6. (**F**) S6 vs S7. (**G**) S7 vs S8. Upregulated transcripts: red. Downregulated transcripts: green. Criteria for flagging differentially expressed transcripts: adjusted p-value\<1e-5, log2 ratio ≥2.322 (five-fold upregulation) or log2 ratio ≤−2.322 (five-fold downregulation), average scaled RPKM value ≥1.0 at indicated time point, transcript has ≥1 ORF. Transcripts derived from transposase or retroviruses were omitted. S2--S8, Stages 2--8. Y, yolk.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.014](10.7554/eLife.21052.014)10.7554/eLife.21052.015Figure 1---figure supplement 3.MA plots for enriched transcripts identified in mixed-stage reference comparisons.(**A**) S2, (**B**) S3, (**C**) S4, (**D**) S5, (**E**) S6, (**F**) S7 and (**G**) S8-enriched transcripts (red) identified using the following criteria: S2--S5 enriched transcripts: p adj \<1e-5; S6--S8-enriched transcripts: p adj \<1e-20. All stages: log2 ratio ≥2.322 (five-fold upregulation), average scaled RPKM value ≥1.0 at indicated time point, transcript has ≥1 ORF. Transcripts derived from transposase or retroviruses were omitted, as were S2, S3 and S4 transcripts also upregulated in yolk. S2--S8: Stages 2--8.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.015](10.7554/eLife.21052.015)10.7554/eLife.21052.016Figure 1---figure supplement 4.Mean centered expression and average RPKM profiles for S2-enriched transcripts.Mean centered expression and average RPKM profiles for S2-enriched transcripts, organized by cluster membership presented in [Figure 1C](#fig1){ref-type="fig"} and [Figure 1---source data 2](#SD2-data){ref-type="supplementary-material"}. S2--S8 Stages 2--8. Y, yolk.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.016](10.7554/eLife.21052.016)10.7554/eLife.21052.017Figure 1---figure supplement 5.Mean centered expression and average RPKM profiles for S3-enriched transcripts.Mean centered expression and average RPKM profiles for S3-enriched transcripts, organized by cluster membership presented in [Figure 1D](#fig1){ref-type="fig"} and [Figure 1---source data 3](#SD3-data){ref-type="supplementary-material"}. S2--S8, Stages 2--8; Y, yolk.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.017](10.7554/eLife.21052.017)10.7554/eLife.21052.018Figure 1---figure supplement 6.Mean centered expression and average RPKM profiles for S4-enriched transcripts.Mean centered expression and average RPKM profiles for S4-enriched transcripts, organized by cluster membership presented in [Figure 1E](#fig1){ref-type="fig"} and [Figure 1---source data 4](#SD4-data){ref-type="supplementary-material"}. S2--S8, Stages 2--8; Y, yolk.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.018](10.7554/eLife.21052.018)10.7554/eLife.21052.019Figure 1---figure supplement 7.Mean centered expression and average RPKM profiles for S5-enriched transcripts.Mean centered expression and average RPKM profiles for S5-enriched transcripts, organized by cluster membership presented in [Figure 1F](#fig1){ref-type="fig"} and [Figure 1---source data 5](#SD5-data){ref-type="supplementary-material"}. S2--S8, Stages 2--8; Y, yolk.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.019](10.7554/eLife.21052.019)10.7554/eLife.21052.020Figure 1---figure supplement 8.Mean centered expression and average RPKM profiles for S6-enriched transcripts.Mean centered expression and average RPKM profiles for S6-enriched transcripts, organized by cluster membership presented in [Figure 1G](#fig1){ref-type="fig"} and [Figure 1---source data 6](#SD6-data){ref-type="supplementary-material"}. S2--S8, Stages 2--8; Y, yolk.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.020](10.7554/eLife.21052.020)10.7554/eLife.21052.021Figure 1---figure supplement 9.Mean centered expression and average RPKM profiles for S7-enriched transcripts.Mean centered expression and average RPKM profiles for S7-enriched transcripts, organized by cluster membership presented in [Figure 1H](#fig1){ref-type="fig"} and [Figure 1---source data 7](#SD7-data){ref-type="supplementary-material"}. S2--S8: Stages 2--8; Y, yolk.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.021](10.7554/eLife.21052.021)10.7554/eLife.21052.022Figure 1---figure supplement 10.Mean centered expression and average RPKM profiles for S8-enriched transcripts.Mean centered expression and average RPKM profiles for S8-enriched transcripts, organized by cluster membership presented in [Figure 1I](#fig1){ref-type="fig"} and [Figure 1---source data 8](#SD8-data){ref-type="supplementary-material"}. S2--S8, Stages 2--8; Y, yolk.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.022](10.7554/eLife.21052.022)10.7554/eLife.21052.023Figure 1---figure supplement 11.Molecular markers for the primitive ectoderm.(**A**) Average RPKM values per embryo for primitive ectoderm markers *gelsolin-like* (*SMED30014940,* blue) and *spondin1-like* (*SMED30032088,* red) during embryogenesis. S2--S8, Stages 2--8; Y, yolk. (**B**--**C**) The number of primitive ectoderm cells remained constant while embryo volume increased during S3--S4. Primitive ectoderm cell nuclei were scored in SPIM reconstructed S3 and S4 embryos. (**B**) During S3, the average number of primitive ectoderm nuclei per embryo was 21.5 ± 2.9. During S4:, the average number of primitive ectoderm nuclei per embryo was 22 ± 1.4. n = 5 embryos. Unpaired t-test, two tailed p value = 0.72. (**C**) Average S3 embryo volume was 7.4 × 10^7^ µm^3^. Average S4 embryo volume was 1.5 × 10^8^ µm^3^. Unpaired t-test, two tailed p value = 0.01. Embryo volumes were calculated by generating a masked surface in Imaris. Twenty-two S3 embryos and five S4 embryos were scored. Error bars represent the standard deviation of the mean. (**D**--**E**) *gelsolin-like* (**D**) and *spondin1-like* (**E**) expression (blue) during embryogenesis (S2-S8). Black arrowheads: temporary embryonic pharynx. Red arrowheads: definitive pharynx. Yellow arrows: primitive ectoderm cells. A, aboral hemisphere; O, oral hemisphere; V, ventral. Scale bars: 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.023](10.7554/eLife.21052.023)10.7554/eLife.21052.024Figure 1---figure supplement 12.Molecular markers for the temporary embryonic pharynx.(**A**--**B**) The temporary embryonic pharynx is innervated by *PC-2+* neurons (**A**) and contains *mhc-1+* radial muscle fibers (**B**). For simplicity, only S4 is shown. The image shown in (**B**) is also shown in [Figure 1---figure supplement 17C](#fig1s17){ref-type="fig"}. (**C**) Average RPKM values per embryo for the temporary embryonic pharynx markers *venom allergen-like* (*VAL-like; SMED30015313*), *macrophage expressed gene one like-1* (*MPEG1-like 1; SMED30000139*), *MPEG1-like 2* (*SMED30034696*) and *netrin-like* (*SMED30023593*) during embryogenesis. S2--S8, Stage 2--8; Y, yolk. (**D**--**G**) Expression of temporary embryonic pharynx specific markers *VAL-like* (**D**, S3--S7), *netrin-like* (**E**, S2--S7), *MPEG1-like-*1 (**F**, S3--S4) and *MPEG1-like-2* (**G**, S3--S4). (**A**--**B**, **D**--**G**) Anterior: top (S6--S8). Black arrowheads: temporary embryonic pharynx. Red arrowheads: definitive pharynx. A, aboral hemisphere; D, dorsal; O, oral hemisphere; V, ventral. Scale bars: 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.024](10.7554/eLife.21052.024)10.7554/eLife.21052.025Figure 1---figure supplement 13.Molecular markers for the developing gut.(**A**, **E**, **H**) Average RPKM values per embryo for (**A**) embryonic gut transcripts *cathepsin L1-like* (*CTSL-like: SMED30023322*), *lysosomal alpha glucosidase-like* (*LYAG-like: SMED30028442, SMED30008977*), *macrophage-expressed gene one like-3* (*MPEG1-like-3: SMED30015696*), (**E**) gamma (γ) class neoblast transcripts (*gata456a, hnf4, prox-1, nkx2.2*), and (**H**) transcripts with enriched expression in the adult gut ([@bib19]; [@bib80]; [@bib88]). S2--S8, Stage 2--8; Y, yolk. Early embryonic gut transcript expression was validated by WISH on staged embryo collections. (**H**) Adult gut-enriched transcripts with enriched expression during S5 and/or S6 (top, n = 146), or S7 and/or S8 (bottom, n = 292). Adult gut-enriched transcripts are flagged in [Figure 1---source data 5](#SD5-data){ref-type="supplementary-material"}--[8](#SD8-data){ref-type="supplementary-material"}. 74% (n = 1,112) of the intestinal phagocyte-enriched transcripts reported in ([@bib19]) were identified in the smed20140614 transcriptome; 129 (11%) of the cross-referenced transcripts were enriched during S5, S6, S7 and/or S8. 90% (n = 425) of the gut-enriched transcripts reported in ([@bib88]) were identified in the smed20140614 transcriptome; 44% (n = 186) of the cross-referenced transcripts were enriched during S5, S6, S7 and/or S8. (**B**--**D**) *CTSL-like* (**B**), *LYAG-like* (**C**) and *MPEG1-like-3* (**D**) expression (blue) in the temporary embryonic pharynx (S2--S4), four primitive gut cells abutting the temporary embryonic pharynx (S4), and yolk-laden gut cells forming an irregular lattice beneath the embryonic wall (S5--S6). Expression of these markers was downregulated as branching morphogenesis proceeded during S7. (**F**--**G**) *gata456a* (**F**) and *hnf4* (**G**) expression (blue) during embryogenesis, S2--S8. Staining was detected in the presumptive temporary embryonic pharynx (S2), and was later detected in scattered parenchymal cells from S5 onwards. Expression of both markers became more prominent in the developing gut over time, especially after branching morphogenesis was underway during S7--S8. (**I**) *porcn-A* expression (blue) during embryogenesis, S2--S8. Hazy, faint expression was detected in the gut during S5--S6, with increasing signal following the initiation of branching morphogenesis during S7--S8. (**B**--**D**, **F**--**G**, **I**) Anterior: top (S6--S8). A, aboral hemisphere; D, dorsal; O, oral hemisphere; V, ventral. Black arrowheads: temporary embryonic pharynx. Black arrows: primitive gut cells. Red arrowheads: definitive pharynx. Scale bars: 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.025](10.7554/eLife.21052.025)10.7554/eLife.21052.026Figure 1---figure supplement 14.:Molecular markers for the definitive pharynx.(**A**) WISH developmental time course using *foxA1* riboprobes (blue), S3--S8. *foxA1* expression was consistently detected in the embryonic pharynx lumen during S3--S5 (black arrowheads). Anterior: top (S6--S8). Black arrowheads: temporary embryonic pharynx. Red arrowheads: definitive pharynx. A, aboral hemisphere; D, dorsal; O, oral hemisphere; V, ventral. Scale bars: 100 µm. (**B**) Average RPKM values per embryo for the definitive pharynx markers *foxA1*, *meis*, *laminin *and *npp-1* during embryogenesis ([@bib1]; [@bib69]). S2-S8, Stage 2--8; Y, yolk.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.026](10.7554/eLife.21052.026)10.7554/eLife.21052.027Figure 1---figure supplement 15.Molecular markers for the definitive epidermis.(**A**, **C**, **F**) Average RPKM values per embryo for: (**A**) zeta (ζ) class neoblast transcripts (**C**) Category 2 and Category 3transcripts, and (**F**) Category 4 and 5 transcripts ([@bib16]; [@bib54]; [@bib76]; [@bib78]; [@bib83]; [@bib90]). S2--S8, Stage 2--8; Y, yolk. Transcripts shown had enriched expression during S5, S6, S7 and/or S8 and are flagged in [Figure 1---source data 5](#SD5-data){ref-type="supplementary-material"}--[8](#SD8-data){ref-type="supplementary-material"}. (**B**, **D**--**E**, **G**--**I**) WISH with riboprobes complementary to: (**B**) *p53*, (**D**) *prog-1*, (**E**) *AGAT-1*, (**G**) *zpuf-6*, (**H**) *vim-3* and (**I**) *crocc* (blue), S3--S8. Anterior: top (S6--S8). D, dorsal; V, ventral. Red arrowheads: definitive pharynx. Red arrows: ciliated protonephridial tubules. Scale bars: 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.027](10.7554/eLife.21052.027)10.7554/eLife.21052.028Figure 1---figure supplement 16.Molecular markers for the developing nervous system.(**A**, **C**) Average RPKM values per embryo for validated and putative adult neural progenitor transcripts ([@bib13]; [@bib14]; [@bib39]; [@bib43]; [@bib45]; [@bib69]; [@bib86]) (**A**) and adult neural classifier transcripts identified in single cell sequencing experiments ([@bib88]) (**C**), Neural transcripts that showed enriched expression during S5, S6, S7 and/or S8 are flagged in [Figure 1---source data 5](#SD5-data){ref-type="supplementary-material"}--[8](#SD8-data){ref-type="supplementary-material"}. 90% (n = 533) of the neural-enriched transcripts reported by [@bib88]) were identified in the smed20140614 transcriptome; 60% (n = 323) of the cross-referenced transcripts were enriched during S5, S6, S7 and/or S8. (**B**, **D**) Expression of the neural progenitor marker *pax6a* (**B**) and the neural marker *synaptotagmin* (*syt,* **D**) (blue), S2--S8. Anterior: top (S6--S8). A, aboral hemisphere; D, dorsal; O, oral hemisphere; V, ventral. Black arrowheads: temporary embryonic pharynx. Red arrowheads: definitive pharynx. Cyan arrows: cephalic ganglia. Cyan arrowheads: ventral nerve cords. Scale bars: 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.028](10.7554/eLife.21052.028)10.7554/eLife.21052.029Figure 1---figure supplement 17.Molecular markers for the developing musculature.(**A**, **C**) Expression of the muscle progenitor marker *myoD* and the mature muscle marker *mhc-1*, S2--S8. Anterior: top (S6--S8). A, aboral hemisphere; D, dorsal; O, oral hemisphere; V, ventral. Black arrowheads: temporary embryonic pharynx. Red arrowheads: definitive pharynx. Cyan arrows: cephalic ganglia. Cyan arrowheads: ventral nerve cords. Scale bars: 100 µm. (**B**, **D**) Average RPKM values per embryo for the putative muscle progenitor marker *myoD* (**B**) and transcripts enriched in adult muscle (**D**). S2--S8, Stages 2--8; Y, yolk. Transcripts in (**D**) showed enriched expression during S5, S6, S7 and/or S8 (n = 166 transcripts, or 42% of the muscle cell-enriched transcripts reported in [@bib88])). Muscle-enriched transcripts are flagged in [Figure 1---source data 5](#SD5-data){ref-type="supplementary-material"}--[8](#SD8-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.029](10.7554/eLife.21052.029)10.7554/eLife.21052.030Figure 1---figure supplement 18.Molecular markers for the developing excretory system.(**A**, **C**) Average RPKM per embryo for transcripts expressed in protonephridia progenitors (*pou2/3, six1/2--2, sal1, eya, osr*) ([@bib70]) (**A**) or differentiated protonephridia ([@bib60]; [@bib70]; [@bib88]) (**C**). Transcripts shown were enriched during S5, S6, S7 and/or S8 and are flagged in [Figure 1---source data 5](#SD5-data){ref-type="supplementary-material"}--[8](#SD8-data){ref-type="supplementary-material"}. (**B**, **D**) WISH developmental time course with riboprobes complementary to the protonephridial progenitor and tubule cell marker *pou2/3* (**B**) or the non-ciliated tubule marker *CAVII-1* (**D**) (blue), S2--S8. Anterior: top (S6--S8). D, dorsal; L, lateral. Red arrowheads definitive pharynx. Scale bars: 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.030](10.7554/eLife.21052.030)10.7554/eLife.21052.031Figure 1---figure supplement 19.Molecular markers for the developing eyes.(**A**, **C**) Average RPKM per embryo for transcripts required for eye progenitor specification (*ovo, six-1/2* and *eya* \[purple\]), photoreceptor neuron differentiation (*otxA* \[(red\]), or pigment cup differentiation (*sp6-9 *and *dlx* \[(blue\]) (**A**), or with enriched expression in adult eye tissue ([@bib39]) (**C**). S2--S8, Stages 2--8; Y, yolk. Transcripts shown were enriched during S5, S6, S7 and/or S8, and are flagged in [Figure 1---source data 5](#SD5-data){ref-type="supplementary-material"}--[8](#SD8-data){ref-type="supplementary-material"}. (**B**, **D**--**E**) WISH developmental time course with riboprobes complementary to *ovo* (**B**), *opsin* (**D**), and *tyrosinase* (**E**), S5--S8. Anterior: top (S6--S8). D: dorsal. Purple arrowheads: developing eye tissue. Blue arrowheads: trail cells (eye progenitors). Scale bars: 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.031](10.7554/eLife.21052.031)

In contrast to the synchronous, oriented blastomere cleavage patterns of Spiralian embryos ([@bib36]), blastomeres in freshwater planarian embryos undergo dispersed cleavage among yolk cells: they divide asynchronously and are not in direct contact with one another ([@bib7]; [@bib10]; [@bib27]; [@bib33]; [@bib40]; [@bib44]; [@bib79]). During sphere formation, some blastomeres differentiate into temporary embryonic cell types that provide form and function to the embryo, including the primitive ectoderm, temporary embryonic pharynx and primitive gut ([@bib10]; [@bib27]; [@bib40]; [@bib68]). Temporary embryonic tissues are not thought to contribute to the juvenile body plan; they are thought to degenerate as the definitive organs form and morphogenesis proceeds ([@bib10]; [@bib40]; [@bib79]). In contrast, undifferentiated blastomeres remaining after sphere formation are thought to give rise to all definitive tissues found in juvenile worms ([@bib27]; [@bib32]; [@bib40]; [@bib68]; [@bib75]).

Several attributes of ectolecithal development challenge efforts to accurately stage live embryos including internal fertilization, dispersed cleavage, lack of morphological landmarks, and inherent variability in embryo size and developmental timing. Extant staging series for *Polycelis nigra* ([@bib40]), *Schmidtea polychroa* ([@bib10]; [@bib42]) and *Girardia tigrina* ([@bib79]) rely upon gross morphological criteria gleaned from live animals and fixed, histologically or antibody-stained specimens. As this is the first systematic characterization of *Smed* embryogenesis, we established an accurate and objective staging method based on unique gene expression signatures, cohorts of enriched transcripts identified through single embryo RNA-Seq , associated with chronological age and embryo morphology ([Figure 1B--I](#fig1){ref-type="fig"}, [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). When appropriate, efforts were made to integrate and adapt extant staging schema from other planarian species.

*Smed* embryos gestate for approximately two weeks at 20°C prior to hatching. We generated total RNA replicates from single *Smed* embryos for seven chronologically and/or morphologically distinct stages (S), S2---S8 ([Figure 1B--I](#fig1){ref-type="fig"}); S1 samples (zygotes, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) were not queried by RNA-SSeq. Yolk (Y) replicates were prepared from egg capsules lacking developing embryos at 8 days post capsule deposition. In addition, single animal replicates were prepared from C4 and virgin sexually mature adults (SX). RNA-Seq libraries were analyzed for four biological replicates (i.e., four individuals) per stage (Materials and methods). Identification of appropriate reference(s) and normalization methods was challenging due to vast differences in sample composition and complexity among different stages. However, clustering of replicates and discrete separation of stages was seen in a multidimensional scaling plot ([Figure 1J](#fig1){ref-type="fig"}). Replicates for a given stage generally showed strong correlation among themselves despite not having controlled for differences in genetic background or embryo size ([Figure 1K](#fig1){ref-type="fig"}). Notably the S2 and S3 replicates, generated from embryos undergoing sphere formation and nascent spheres, respectively, were intermingled in expression space, showed the greatest variability and few significant differences in gene expression ([Figure 1J--K](#fig1){ref-type="fig"}, [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Discrete stages were retained due to apparent differences in embryo morphology ([Figure 1C--D](#fig1){ref-type="fig"}). Similarities among S2 and S3 samples may be due to maternal RNA contribution or to difficulty detecting labile S2 embryos, such that only well-developed S2 embryos were prospected by RNA-Seq.

Two approaches were used to identify differentially expressed transcripts: pairwise comparisons of adjacent stages ([Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"})and comparisons of each stage relative to a mixed stage reference generated by averaging the read counts for the remaining replicates (Y, S2--S8) (Materials and methods, [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}, [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). The goal of the pairwise comparisons was to identify transcripts with the starkest changes in expression in either direction, without constraints on transcript behavior at other points during embryogenesis. In contrast, the mixed stage reference comparisons maximized the likelihood of identifying transcripts exhibiting stage-specific expression, and only upregulated transcripts were analyzed. Stringent criteria were applied in both scenarios for flagging differentially expressed transcripts, including thresholds based on the Benjamini-Hochberg adjusted p-value, fold-change, normalized RPKM expression level for time points, and identification of at least one open reading frame in the transcript ([Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). More upregulated transcripts were identified in the mixed stage reference than in pairwise comparisons, perhaps due to increased sequencing depth of the averaged reference samples, which may enable more reliable detection of lowly expressed transcripts. Furthermore, identification of S2-enriched transcripts suggested that the whole embryo sequencing approach was sensitive enough to detect transcripts expressed in rare cell populations (i.e., blastomeres and differentiated cells making up the embryo proper). Non-redundant lists of upregulated transcripts, resulting from the union of the pairwise and mixed reference comparisons, served as molecular fingerprints for each time point for downstream analyses, including hierarchical clustering and GO analysis ([Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). The molecular staging resource ([Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}) incorporates representative images ([Figure 1C--I](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), gene expression signatures ([Figure 1---figure supplements 4](#fig1s4){ref-type="fig"}--[10](#fig1s10){ref-type="fig"}, [Figure 1---source data 2](#SD2-data){ref-type="supplementary-material"}--[8](#SD8-data){ref-type="supplementary-material"}) and written summaries of key developmental events ([Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}), defining S1--S8. An expression atlas describing temporary embryonic tissue types and development of the definitive organ systems is also provided ([Figure 1---source data 9](#SD9-data){ref-type="supplementary-material"}, [Figure 1---figure supplements 11](#fig1s11){ref-type="fig"}--[19](#fig1s19){ref-type="fig"}). The molecular staging resource and expression atlas are also available and searchable online (<https://planosphere.stowers.org>).

Anarchic, cycling *piwi-1+* blastomeres fuel *Smed* embryonic development {#s2-2}
-------------------------------------------------------------------------

The molecular staging series identified S2- and S3-enriched transcripts ([Figure 1C--D](#fig1){ref-type="fig"}, [Figure 1---source data 2](#SD2-data){ref-type="supplementary-material"}--[3](#SD3-data){ref-type="supplementary-material"}), including *elongation factor 1a-like-1* (*EF1a-like-1*), expressed in all known embryonic cell populations in nascent spherical embryos ([Figure 2A--B](#fig2){ref-type="fig"}). During S2, primitive ectoderm cells are the first to differentiate ([@bib27]; [@bib33]; [@bib40]; [@bib44]). *EF1a-like-1* was expressed in primitive ectoderm cells ([Figure 2A--B](#fig2){ref-type="fig"}, [Video 1](#media1){ref-type="other"}), which flatten, elaborate numerous cytoplasmic processes, and form a single-cell layer bounding the sphere ([Figure 1---source data 9](#SD9-data){ref-type="supplementary-material"}, [Figure 1---figure supplement 11](#fig1s11){ref-type="fig"}). *EF1a-like-1* expression was also detected in the temporary embryonic pharynx ([Figure 2A--B](#fig2){ref-type="fig"}, [Video 1](#media1){ref-type="other"}) an innervated pump containing neurons, radial muscle and associated epithelial cells ([Figure 1---source data 9](#SD9-data){ref-type="supplementary-material"}, [Figure 1---figure supplement 12](#fig1s12){ref-type="fig"}), and in the primitive endoderm ([Figure 2A](#fig2){ref-type="fig"}), which consists of an inner gut cavity and phagocytic cells associated with the temporary embryonic pharynx ([Figure 1---source data 9](#SD9-data){ref-type="supplementary-material"}, [Figure 1---figure supplement 13](#fig1s13){ref-type="fig"}). A population of undifferentiated blastomeres and yolk cells remain in the embryonic wall, the parenchymal space between the primitive ectoderm and endoderm, in nascent S3 spheres ([Figure 1D](#fig1){ref-type="fig"}) ([@bib32]; [@bib68]). *EF1a-like-1* was expressed in undifferentiated blastomeres, but not yolk cells, in S3 embryos ([Figure 2A--B](#fig2){ref-type="fig"}, [Video 1](#media1){ref-type="other"}).10.7554/eLife.21052.032Figure 2.Blastomere anarchy drives *Smed* embryogenesis.(**A**--**B**) Architectural features of S2 and S3 embryos. (**A**) Expression of the pan embryonic cell marker *EF1a-like-1* (blue) in S2 (left) and S3 (right) embryos. Cyan arrowheads: primitive ectoderm cells. Cyan arrows: undifferentiated blastomeres. Red arrowhead: temporary embryonic pharynx. Red arrows: primitive gut cells. (**B**) S3 embryo stained with *EF1a-like-1* riboprobes (red) and sytox green nuclear counterstain (green). Cyan arrowheads: primitive ectoderm cells. Cyan arrows: undifferentiated blastomeres. Yellow arrowhead: temporary embryonic pharynx. (**C**) Confocal Z-slice of an ovary from a sexually mature *Smed* hermaphrodite stained with *piwi-1* riboprobes (green) and DAPI (blue). Yellow arrows: oocytes. (**D**) Dispersed cleavage. S2 embryo stained with *piwi-1* riboprobes (red, blastomeres) and antibodies raised against the mitotic epitope H3S10p (green). Nuclei stained with DAPI (blue). Yellow arrow: dividing blastomere. (**E**) *piwi-1* is expressed in undifferentiated blastomeres of S3 embryos. S3 embryo costained with riboprobes complementary to *piwi-1* (red) and *EF1a-like-1* (green). 100% *piwi-1+* blastomeres coexpressed *EF1a-like-1*. n = 159 cells scored, n = 5 S3 embryos. Cyan arrows: undifferentiated blastomeres. Yellow arrowhead: temporary embryonic pharynx. Red arrows: fiduciary beads used for SPIM reconstruction. (**F**) *piwi-1*+ cells are located in the embryonic wall. Paraffin-embedded cross-section of a S3 sphere stained with *piwi-1* riboprobes (blue) and eosin (pink). Cyan arrows: *piwi-1+* cells. GC: yolk-filled gut cavity. Inset: magnified view of a *piwi-1+* cell. Scale: 25 µm. (**G**) Left: Average RPKM per embryo for *piwi-1 *(S2--S8). Right: WISH developmental time course with *piwi-1* riboprobes (blue) (S2--S8). O, oral hemisphere; V, ventral. (**A**--**G**) Scale: 100 µm. Left: Observed distribution of *piwi-1+* cells in S3--S4 embryos (blue bars) relative to the oral-aboral axis (0--3.14 radians). Maximum likelihood analysis best described distribution by the function ((1-exp(-θ/θ'))\*sin(θ), blue line). The optimal calculated θ' was 0.45 ± 0.045 radians, based on simulations with comparably sized data sets, and was several orders of magnitude more likely to explain the observed distribution than the theoretical normal distribution, sin(θ), (θ' = 0), red line. S3: n = 32 embryos, n = 1,746 *piwi-1+* cells scored. S4: n = 8 embryos, 2,665 *piwi-1+* cells scored. Right: observed *piwi-1+* cell distributions for individual S3 (top) and S4 (bottom) embryos. (**C**--**G**) *piwi-1+* cells are detected throughout embryogenesis. (**H**) *piwi-1*+ cell positions are not stereotyped in S3--S4 embryos.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.032](10.7554/eLife.21052.032)Video 1.S3 embryo architecture.SPIM reconstructed S3 embryo costained with *EF1a-like-1* (red) and sytox green nuclear counterstain. *EF1a-like-1* is a pan-embryonic cell marker that stains primitive ectoderm cells, the temporary embryonic pharynx and undifferentiated blastomeres in the embryonic wall. *EF1a-like-1* staining is absent from yolk cells in the embryonic wall and gut cavity.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.033](10.7554/eLife.21052.033)10.7554/eLife.21052.033

*piwi-1+* cells were present throughout embryogenesis. *piwi-1* expression was detected in oocytes ([Figure 2C](#fig2){ref-type="fig"}), suggesting that zygotes contain *piwi-1* mRNA. Zygote-derived blastomeres undergoing dispersed cleavage among yolk cells during S2 also expressed *piwi-1* ([Figure 2D](#fig2){ref-type="fig"}). Costaining with *piwi-1* riboprobes and antibodies raised against the G2-M phase mitotic marker H3S10p showed that *piwi-1+* blastomeres divide asynchronously during S2 ([Figure 2D](#fig2){ref-type="fig"}).

As spheres form during S2, some blastomeres downregulate *piwi-1* expression and differentiate into temporary embryonic cell types. *piwi-1* expression was restricted to, and expressed throughout, the undifferentiated blastomere population in S3 embryos, as demonstrated by double fluorescent WISH with *EF1a-like-1* and *piwi-1* riboprobes ([Figure 2E](#fig2){ref-type="fig"}, [Video 2](#media2){ref-type="other"}). *piwi-1+* blastomeres were always located in the embryonic wall ([Figure 2F](#fig2){ref-type="fig"}). *piwi-1* expression was never detected in the primitive ectoderm, temporary embryonic pharynx or primitive gut ([Figure 2E,G](#fig2){ref-type="fig"}). During S3--S5, *piwi-1+* cell number clearly increased, effectively blanketing the sphere ([Figure 2G](#fig2){ref-type="fig"}). As definitive gut development proceeded during S6--S8, *piwi-1+* cells occupied the parenchyma between the developing gut branches ([Figure 2G](#fig2){ref-type="fig"}). Notably, *piwi-1+* cells were not detected in the definitive pharynx, and the compartment receded from the anterior margin as head structures developed ([Figure 2G](#fig2){ref-type="fig"}). By S8, the spatial distribution of *piwi-1+* cells was indistinguishable from that of the adult neoblast compartment ([Figure 2G](#fig2){ref-type="fig"}).Video 2.*piwi-1* is expressed in all undifferentiated blastomeres of S3 embryos.SPIM reconstructed S3 embryo costained with *piwi-1* (red) and *EF1a-like-1* (green). *piwi-1* is expressed in all undifferentiated blastomeres in the embryonic wall (*piwi-1+, EF1a-like-1+* cells). *piwi-1* is not expressed in differentiated tissues marked by *EF1a-like-1* alone, including the primitive ectoderm and temporary embryonic pharynx (green). Several fluorescent beads used for three-dimensional reconstruction are visible (red).**DOI:** [http://dx.doi.org/10.7554/eLife.21052.034](10.7554/eLife.21052.034)10.7554/eLife.21052.034

Analysis of *piwi-1+* cell positions in S3--S4 embryos revealed that undifferentiated blastomeres were spatially disordered, or 'anarchic,' as described for other freshwater flatworms ([@bib7]; [@bib10]; [@bib27]; [@bib33]; [@bib40]; [@bib44]; [@bib79]). The observed distribution of *piwi-1+* cells in S3--S4 embryos with respect to the temporary embryonic pharynx ([Figure 2H](#fig2){ref-type="fig"}, blue line) was nearly identical to that of a random distribution ([Figure 2H](#fig2){ref-type="fig"}, red line). Fewer *piwi-1+* cells were located adjacent to the oral pole than was predicted for a theoretical normal distribution, perhaps due to spatial constraints imposed by the temporary embryonic pharynx and associated primitive gut cells ([Figure 2H](#fig2){ref-type="fig"}). We used a simple dampening term and maximum likelihood estimation to account for the deviation between the observed and theoretical normal distributions ([Figure 2H](#fig2){ref-type="fig"}). However, the distribution of *piwi-1*+ cells in the embryonic wall was not stereotyped; it varied greatly across individuals ([Figure 2H](#fig2){ref-type="fig"}).

Strikingly, cell cycle activity was restricted to *piwi-1+* cells at all developmental stages assayed, and all *piwi-1+* cells in early embryos were cycling. Expression of the cell cycle regulators *PCNA* and *RRM2-2* closely mimicked that of *piwi-1* during embryogenesis, both with respect to the spatial distribution of positive cells and trends observed in the RNA-Seq data ([Figures 2G](#fig2){ref-type="fig"} and [3A--B](#fig3){ref-type="fig"}). Double fluorescent WISH on S3--S5 embryos revealed that *PCNA* and *RRM2-2* were expressed exclusively in *piwi-1+* blastomeres, all of which were cycling ([Figure 3C--D](#fig3){ref-type="fig"}, [Videos 3](#media3){ref-type="other"}--[4](#media4){ref-type="other"}). S3--S5 embryos costained with *piwi-1* and H3S10p antibodies confirmed that mitotic activity was restricted to *piwi-1+* blastomeres ([Figure 3E](#fig3){ref-type="fig"}, [Video 5](#media5){ref-type="other"}). Consistent with observations made in S2 embryos ([Figure 2D](#fig2){ref-type="fig"}), cell divisions were asynchronous during S3--S5. The mitotic index for S3--S5 *piwi-1+* blastomeres was stable, with no statistically significant difference in the calculated division rate ([Figure 3F](#fig3){ref-type="fig"}). Analysis of mitotic (*piwi-1+,* H3S10p+) cell positions along the oral-aboral axis in S3--S4 embryos did not reveal regional biases in mitotic activity across samples ([Figure 3G](#fig3){ref-type="fig"}).10.7554/eLife.21052.035Figure 3.Cell cycle activity is restricted to the *piwi-1+* compartment.(**A**--**B**) Left: Colorimetric WISH depicting expression of *PCNA* (**A**) or *RRM2-2* (**B**) during stages S2--S8. Right: Average RPKM values per embryo for *PCNA* (**A**) or *RRM2-2* (**B**) in Y (yolk) and S2--S8. V, ventral. Scale: 100 µm. (**C**--**D**) S3 (top), S4 (middle) and S5 (bottom) embryos costained with *piwi-1* (red) and *PCNA* (green \[**C**\]) or *RRM2-2* (green \[**D**\]) riboprobes. The percentage of *piwi-1+* cells coexpressing the indicated cell cycle marker (red) and the percentage of *PCNA+* or *RRM2-2+* cells coexpressing *piwi-1* (green) appear in the lower left corner of merged images. Scale bars: 100 µm. (**C**) S3: n = 273 cells, n = 6 embryos. S4: n = 1,267 cells, n = 4 embryos. S5: n = 734 cells, n = 3 embryos. (**D**) S3: n = 130 cells, n = 4 embryos. S4: n = 1,295 cells, n = 5 embryos. S5: n = 350 cells, n = 3 embryos. (**E**) Mitotic activity is restricted to the *piwi-1+* cell compartment in S3--S5 embryos. Left: S4 embryo costained with *piwi-1* and the embryonic pharynx marker *LYAG-like* (both in green) and antibodies against the mitotic epitope H3S10p (red). White arrows: dividing blastomeres. White arrowhead: temporary embryonic pharynx. Scale bar: 100 µm. Right: Bar graph depicting the percentage of mitotic cells scored that expressed *piwi-1* in S3--S5 embryos. (**F**) The mitotic index for the *piwi-1+* cell compartment did not vary significantly during S3--S5. Average percentage of *piwi-1+* cells in mitosis during S3--S5. Error bars represent the standard deviation of the mean. Observed distribution of mitotic (*piwi-1+*, H3S10p+) cells in S3---S4 embryos (blue bars) along the oral-aboral axis (0--3.14 radians). Using the function derived with maximum likelihood estimation for the *piwi-1+* cell distribution, (1-exp(-θ/θ'))\*sin(θ) (blue line), and simulations using equivalent sample sizes, the optimal θ' was calculated to be 0.58 ± 0.33, and was 50-fold more likely to explain the observed trend than a simple normal distribution, sin(θ), where θ'=0 (red line). S3: n = 82 mitotic cells, n = 18 embryos. S4: n = 110 mitotic cells, n = 8 embryos. (**G**) Mitotic cell positions are not stereotyped in early embryos.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.035](10.7554/eLife.21052.035)Video 3.Cell cycle activity is restricted to *piwi-1* blastomeres, and all blastomeres are cycling.SPIM reconstructed S4 embryo costained with *piwi-1* (red) and *PCNA* (green). *PCNA* expression is restricted to *piwi-1+* blastomeres, and all *piwi-1+* cells co-express *PCNA.***DOI:** [http://dx.doi.org/10.7554/eLife.21052.036](10.7554/eLife.21052.036)10.7554/eLife.21052.036Video 4.Cell cycle activity is restricted to *piwi-1* blastomeres, and all blastomeres are cycling.SPIM reconstructed S4 embryo costained with *piwi-1* (red) and *RRM2-2* (green). *RRM2-2* expression is restricted to *piwi-1+* blastomeres, and all *piwi-1+* cells co-express *RRM2-2.* Several fluorescent beads used for three-dimensional reconstruction are visible (red).**DOI:** [http://dx.doi.org/10.7554/eLife.21052.037](10.7554/eLife.21052.037)10.7554/eLife.21052.037Video 5.Mitotic activity is restricted to *piwi-1+* blastomeres, which cycle asynchronously.SPIM reconstructed S4 embryo costained with *piwi-1* and *LYAG-like* (both in green) and H3S10p antibodies (red). *LYAG-like* marks the temporary embryonic pharynx and is not expressed in *piwi-1+* blastomeres. Several examples of *piwi-1+*, H3S10p+ cells are evident.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.038](10.7554/eLife.21052.038)10.7554/eLife.21052.038

Several striking parallels may be drawn regarding cell cycle behavior of the *piwi-1+* population during embryogenesis and adulthood. First, cell cycle activity is largely restricted to this compartment in both contexts, with exception of the male and female germline in sexually mature adults ([@bib6]; [@bib48]; [@bib58]; [@bib84]; [@bib85]). Second, cycling cells and mitotic figures do not display obvious positional biases within the parenchyma in either S3--S5 embryos or adults during homeostasis ([@bib48]). Little substantiating evidence exists in support of a quiescent *piwi-1+* cell population during embryogenesis or adulthood ([@bib48]), and differences in cell cycle length were not observed between neoblast subclasses in adult asexual animals ([@bib78]). Finally, the staggering net increase in *piwi-1+* blastomeres during S3--S5 suggests a capacity for self-renewal, a property possessed by neoblasts.

Many adult asexual stem cell genes are expressed throughout embryonic development {#s2-3}
---------------------------------------------------------------------------------

Numerous neoblast-enriched transcripts, identified through whole asexual animal irradiation studies and cell sorting ([@bib16]; [@bib35]; [@bib63]; [@bib72]; [@bib83]; [@bib88]), have been vetted for co-expression with *piwi-1+* and ascribed function(s) in neoblast proliferation, maintenance or cell fate commitment. Some neoblast-enriched transcripts, including those encoding nuage components and cell cycle regulators, are expressed in all neoblasts, whereas others are predominantly expressed in subpopulation(s) of cells that may be primed to adopt differentiated fates ([@bib78]). To address similarities in the gene expression profiles of the *piwi-1+* population during embryogenesis and adulthood, the expression trends of 242 adult asexual neoblast-enriched transcripts were examined using the molecular staging series data. Neoblast-enriched transcript membership was determined by sequences downregulated in whole animals following lethal irradiation across three independent experiments ([@bib15]; [@bib83]) (Chen and Sánchez Alvarado, personal communication). Strikingly, most adult asexual neoblast-enriched transcripts were expressed throughout embryogenesis ([Figure 4A](#fig4){ref-type="fig"}, [Figure 4---source data 1](#SD10-data){ref-type="supplementary-material"}). 74% (n = 180) of the neoblast-enriched transcripts had average RPKM values per embryo ≥1.0 in S2 embryos and 52% (n = 128) transcripts had five-fold or greater expression levels in S2 embryos versus yolk, raising the possibility that other adult stem cell genes were expressed in blastomeres. Consistent with this idea, 41% of the adult asexual neoblast-enriched transcripts (n = 99) were present in the molecular expression signature(s) for S2--S5 embryos ([Figure 1---source data 2](#SD2-data){ref-type="supplementary-material"}--[5](#SD5-data){ref-type="supplementary-material"}, [Figure 4---source data 1](#SD10-data){ref-type="supplementary-material"}). Expression of neoblast-enriched transcripts usually peaked during S4 or S5, prior to construction of the definitive organ systems, and diminished thereafter ([Figure 4A](#fig4){ref-type="fig"}, [Figure 4---source data 1](#SD10-data){ref-type="supplementary-material"}). The apparent decrease in expression after S5 was likely attributable to drastic changes in the complexity of the single embryo RNA samples during organogenesis, and was similarly observed for *piwi-1* and the cell cycle regulators *PCNA* and *RRM2-2* ([Figures 2G](#fig2){ref-type="fig"} and [3A--B](#fig3){ref-type="fig"}, [Figure 4---source data 1](#SD10-data){ref-type="supplementary-material"}).10.7554/eLife.21052.039Figure 4.Many adult neoblast markers are similarly expressed throughout the *piwi-1+* compartment during embryogenesis.(**A**) Many transcripts with adult asexual neoblast-enriched expression are expressed throughout embryogenesis. Hierarchical clustering of 242 adult asexual neoblast-enriched transcripts during embryonic development using normalized mixed stage reference comparison data. Left: Heat map. Colored bars (left) denote clusters. Right: Normalized average RPKM values per embryo, plotted as a function of developmental time, for Clusters 1--8. Y, yolk; S2--S8, Stages 2--8. (**B**--**E**) Colorimetric WISH depicting expression of *piwi-2* (**B**)*, piwi-3* (**C**)*, tud-1* (**D**) and *bruli-1* (**E**) during embryogenesis (blue) (S2--S8). V, ventral. Black arrowheads: temporary embryonic pharynx. Red arrowheads: definitive pharynx. Scale bars: 100 µm. (**F**--**I**) Many markers of the adult asexual neoblast compartment are also expressed in *piwi-1+* blastomeres. Fluorescent WISH on S4 embryos with riboprobes against *piwi-1* (red) and *piwi-2* (**F**), *piwi-3* (**G**), *tud-1* (**H**) or *bruli-1* (**I**) (green). Percentage of *piwi-1+* cells coexpressing the indicated marker (red) and the percentage of the indicated adult asexual neoblast marker coexpressing *piwi-1* (green) appears in the lower left corner of merged images. Scale bars: 100 µm. (**F**) n = 435 cells, n = 9 S3--S4 embryos. (**G**) n = 535 cells, n = 5 S3--S4 embryos. (**H**) n = 1,867 cells, n = 8 S3--S5 embryos. (**I**) n = 1,353 cells, n = 3 S4 embryos.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.039](10.7554/eLife.21052.039)10.7554/eLife.21052.040Figure 4---source data 1.Hierarchical clustering analysis for 242 adult asexual neoblast-enriched transcripts.Clustering was performed using normalized expression data from the mixed stage reference comparison. Normalized expression profiles, cluster membership, average RPKM values across embryogenesis (Y--S8) and for C4 and SX adults, as well as best BLASTx hits (E \< 0.001) versus the NR, Swiss-Prot, *C. elegans, D. melanogaster, D. rerio, X. tropicalis, M. musculus* and *H. sapiens* RefSeq databases are provided.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.040](10.7554/eLife.21052.040)10.7554/eLife.21052.041Figure 4---figure supplement 1.Adult asexual neoblast-enriched markers are coexpressed in *piwi-1+* cells during embryogenesis.(**A**,**C**) Colorimetric WISH depicting expression of *SoxP-1* (**A**) and *SoxP-2* (**C**) during embryogenesis (S2--S8). V, ventral. Scale bars: 100 µm. (**B**) Average RPKM per embryo for *SoxP-1* (blue) and *SoxP-2* (red). Y, yolk; S2--S8, Stages S2--S8. ([**D**]{.smallcaps}--**G**) Fluorescent WISH costaining on S3--S5 embryos using riboprobes against *piwi-1* (red) and *piwi-2* (**D**), *piwi-3* (**E**), *tud-1* (**F**), or Y12 antibodies (S4--S5 only)(**G**) (green). Scale bars: 100 µm. (**D**--**E**) S3 and S5 costained samples. S4 samples and quantification are depicted in the [Figure 4F--I](#fig4){ref-type="fig"} legend. (**G**) 98% *piwi-1+* cells costained with Y12 antibodies. 96% Y12-positive cells costained with *piwi-1,* n = 913 cells, n = 7 S4--S5 embryos.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.041](10.7554/eLife.21052.041)

Hierarchical clustering of the 242 adult asexual neoblast-enriched transcripts revealed correlated expression of genes associated with DNA replication (e.g., the replication licensing factors *MCM2* and *MCM5*), DNA repair (e.g., *fancd2-like, msh2* and *msh6*) and cell cycle progression (e.g., *cyclin D-like,* c*yclin-B1* and *cyclin-B2*) during embryogenesis, and the expression trends for these genes mimicked those of *PCNA* and *piwi-1* ([Figure 4A](#fig4){ref-type="fig"} \[Cluster 1\], [Figure 4---source data 1](#SD10-data){ref-type="supplementary-material"}). Notably, transcripts encoding the nuage-associated factors *piwi-2* and *piwi-3*, the RNA-binding protein *bruli-1*, and the transcription factors *SoxP-1* and *junL1-1*, all genes previously implicated in neoblast maintenance or function ([@bib26]; [@bib52]; [@bib58]; [@bib83]), were also coregulated with *piwi-1* during embryogenesis ([Figure 4A](#fig4){ref-type="fig"} \[Cluster 3\], [Figure 4---source data 1](#SD10-data){ref-type="supplementary-material"}). Consistent with the expression trends detected by RNA-Seq and the previously reported expression pattern for *Schmidtea polychroa* (*Spol*) *tud-1* ([@bib73]), *piwi-2, piwi-3, tud-1, bruli-1, Sox-P1* and *Sox-P2* were expressed in cells with similar morphology and distribution to the *piwi-1+* population during embryogenesis ([Figure 4B--E](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1A--C](#fig4s1){ref-type="fig"}). Double fluorescent WISH revealed coincident expression of *piwi-1* and the adult stem cell markers *piwi-2, piwi-3, tud-1* and *bruli-1* in S3--S5 embryos ([Figure 4F--I](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1D--F](#fig4s1){ref-type="fig"}, [Videos 6](#media6){ref-type="other"}--[9](#media9){ref-type="other"}). Y12 antibodies, which label chromatoid bodies in adult neoblasts ([@bib65]), stained *piwi-1+* blastomeres during S4---S5 ([Figure 4---figure supplement 1G](#fig4s1){ref-type="fig"}, [Video 10](#media10){ref-type="other"}). Taken together, these findings suggest that many adult asexual neoblast markers, including genes implicated in DNA replication and repair, cell cycle control, chromatin remodeling and/or modification, genome surveillance and pluripotency, are also likely to be expressed throughout the *piwi-1+* population during embryogenesis. Moreover, shared elements of the blastomere and neoblast expression signatures, including DNA replication and repair pathway, cell cycle, nuage and RNA processing genes, are prominent features of an evolutionarily conserved gene expression signature for metazoan primordial stem cells ([@bib3]).Video 6.*piwi-1+* blastomeres co-express the adult asexual neoblast-enriched gene *piwi-2.*SPIM reconstructed S4 embryo costained with *piwi-1* (red) and *piwi-2* (green). *piwi-1+* blastomeres co-express the nuage factor *piwi-2,* and virtually all *piwi-2+* cells co-express *piwi-1.* Several fluorescent beads used for three-dimensional reconstruction are visible (green).**DOI:** [http://dx.doi.org/10.7554/eLife.21052.042](10.7554/eLife.21052.042)10.7554/eLife.21052.042Video 7.*piwi-1+* blastomeres co-express the adult asexual neoblast-enriched gene *piwi-3.*SPIM reconstructed S4 embryo costained with *piwi-1* (red) and *piwi-3* (green). *piwi-1+* blastomeres co-express the nuage factor *piwi-3*, and virtually all *piwi-3+* cells co-express *piwi-1.***DOI:** [http://dx.doi.org/10.7554/eLife.21052.043](10.7554/eLife.21052.043)10.7554/eLife.21052.043Video 8.*piwi-1+* blastomeres co-express the adult asexual neoblast-enriched gene *tud-1.*SPIM reconstructed S4 embryo costained with *piwi-1* (red) and *tud-1* (green). *piwi-1+* blastomeres co-express the nuage factor *tud-1*, and virtually all *tud-1+* cells co-express *piwi-1.***DOI:** [http://dx.doi.org/10.7554/eLife.21052.044](10.7554/eLife.21052.044)10.7554/eLife.21052.044Video 9.*piwi-1+* blastomeres co-express the adult asexual neoblast-enriched gene *bruli-1.*SPIM reconstructed S4 embryo costained with *piwi-1* (red) and *bruli-1* (green). *piwi-1+* blastomeres co-express the stem cell maintenance gene *bruli-1*, and virtually all *bruli-1+* cells co-express *piwi-1.* Several fluorescent beads used for three-dimensional reconstruction are visible (red).**DOI:** [http://dx.doi.org/10.7554/eLife.21052.045](10.7554/eLife.21052.045)10.7554/eLife.21052.045Video 10.*piwi-1+* blastomeres possess chromatoid bodies.SPIM reconstructed S4 embryo costained with *piwi-1* (red) and Y12 antibodies (green). Y12 antibody staining was restricted to, and present throughout, the *piwi-1+* blastomere population.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.046](10.7554/eLife.21052.046)10.7554/eLife.21052.046

Early-embryo-enriched transcripts expressed throughout *piwi-1+* blastomeres are downregulated as organogenesis begins {#s2-4}
----------------------------------------------------------------------------------------------------------------------

Hierarchical clustering of S2---S4-enriched transcripts using scaled RPKM values identified 1,048 sequences in Clusters 5, 6 and 8 that were downregulated by S5 and remained lowly expressed through S8; these sequences are referred to as early-embryo-enriched (EEE) transcripts ([Figure 5A](#fig5){ref-type="fig"}, [Figure 5---source data 1](#SD11-data){ref-type="supplementary-material"}). EEE transcripts were likely expressed in blastomeres and/or temporary embryonic tissues, as 98% of the sequences had average expression values at least five-fold greater in S2 embryos than in Y ([Figure 5---source data 1](#SD11-data){ref-type="supplementary-material"}). Most EEE transcripts were expressed at low levels in intact adults regardless of biotype: average RPKM values less than 1.0 were recorded for 65% and 59% of the EEE transcripts in C4 or SX, respectively ([Figure 5---source data 1](#SD11-data){ref-type="supplementary-material"}).10.7554/eLife.21052.047Figure 5.Early-embryo-enriched transcripts are downregulated as organogenesis begins.(**A**) Hierarchical clustering of S2--S4-enriched transcripts (n = 1,756) using scaled RPKM data. Left: Heat map. Y, yolk. Colored bars (left) denote Clusters 5, 6 and 8 containing early-embryo-enriched (EEE) transcripts. Cluster f5 sequences (blue, n = 413) were expressed at roughly equivalent levels during S2 and S3, with 66% (n = 275) transcripts showing five-fold or greater declines in average expression values between S3 and S5. Cluster 6 sequences (red, n = 523) exhibited maximal expression during S2, and average expression levels declined more than five-fold between S2 and S4 for 81% (n = 426) of these transcripts. Cluster 8 sequences (green, n = 112) showed peak expression during S4, with 52% (n = 60) of the transcripts showing five-fold or greater declines in average expression values by S5. Right: Normalized expression trends for EEE transcripts in Clusters 5 (blue), 6 (red) and 8 (green) plotted as a function of developmental time. Median 50% of transcripts based on expression maxima are plotted. ([**B**]{.smallcaps}--**E**) Colorimetric WISH depicting expression of the EEE transcripts *tct-like* (**B**), *BTF3-like* (**C**), *DDX5-like* (**D**) and *eIF4a-like* (**E**) (blue) in S2--S8 embryos and C4 asexual adults. Black arrowheads: temporary embryonic pharynx. Red arrowheads: definitive pharynx. O, oral; V, ventral. Scale bars: 100 µm. (**F**--**I**) EEE transcripts were expressed throughout the *piwi-1+* compartment in S3--S4 embryos. Fluorescent double WISH with riboprobes against *piwi-1* (red) and the EEE transcripts *tct-like* (**F**), *BTF3-like* (**G**), *DDX5-like* (**H**) and *eIF4a-like* (**I**) (green) in S4 embryos. Percentage *piwi-1+* cells coexpressing the indicated EEE marker (red) and percentage EEE+ cells coexpressing *piwi-1* (green) appear in the lower left corner of merged images. (**F**) n = 895 *piwi-1+* cells, n = 905 *tct-like+* cells, n = 7 S3--S4 embryos. (**G**) n = 692 *piwi-1+* cells, n = 728 *BTF3+* cells, n = 6 S3--S4 embryos. (**H**) n = 676 *piwi-1+* cells, n = 681 *DDX5-like+* cells, n = 5 S3--S4 embryos. (**I**) n = 312 *piwi1+* cells, n = 332 *eIF4a+* cells, n = 4 S3--S4 embryos.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.047](10.7554/eLife.21052.047)10.7554/eLife.21052.048Figure 5---source data 1.Hierarchical clustering of S2--S4-enriched transcripts across embryogenesis.S2--S4 transcripts (n = 1,756) were clustered using scaled RPKM values across embryogenesis (Y, S2--S8). Cluster membership and average RPKM values (Y--S8, C4 and SX) are provided. Early-embryo-enriched (EEE) transcripts (n = 1,048), which were downregulated by S5 and were lowly expressed through S8, comprise Clusters 5, 6 and 8. Separate tabs for EEE transcript Clusters 5, 6 and 8 include annotation based on best BLASTx hits (E \< 0.001) versus the NR, Swiss-Prot, *C. elegans, D. melanogaster, D. rerio, X. tropicalis, M. musculus* and *H. sapiens* RefSeq databases.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.048](10.7554/eLife.21052.048)10.7554/eLife.21052.049Figure 5---source data 2.Validation of transcript expression trends using the Nanostring nCounter platform.**Normalized Nanostring data tab:** Normalized expression counts for positive ERCC spike-in controls (POS A--F), negative controls (NEG A--H), housekeeping genes, the blastomere and mitotic cell markers *H2B* and *piwi-1*, the differentiating progenitor marker *prog-1,* and 107 early-embryo-enriched (EEE) transcripts. **Clusters tab**: hierarchical clustering results for 107 EEE transcripts using normalized count data. **Raw data tab**: raw expression count data for positive ERCC spike-in controls (POS A--F), negative controls (NEG A--H), housekeeping genes, the blastomere and mitotic cell markers *H2B* and *piwi-1*, the differentiating progenitor marker *prog-1,* and 107 EEE transcripts. **Nanostring probe sequences tab**: target sequence region for capture and reporter probes.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.049](10.7554/eLife.21052.049)10.7554/eLife.21052.050Figure 5---source data 3.EEE transcript expression patterns detected by colorimetric WISH.Colorimetric whole mount in situ hybridization screen results detail expression patterns across embryos and C4 intact adults for select EEE transcripts. Numbers in parentheses indicate the number of embryos scored with expression in a given tissue (numerator) versus the total number of embryos scored (denominator). pT4P-EEE transcript plasmid insert and cloning primer sequences are also provided.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.050](10.7554/eLife.21052.050)10.7554/eLife.21052.051Figure 5---figure supplement 1.Validation of early-embryo-enriched transcript expression trends using the Nanostring nCounter platform.(**A**) Count sums for positive controls(left), housekeeping genes (middle) and experimental probes (right) for four biological replicates per sample: yolk (Y), S2--S8 embryos, C4 asexual adults (C4) and virgin sexually mature adults (SX). Note the low read counts for the experimental S2 samples. (**B**) Log-scale plot of count sums for positive controls (POSITIVE A--F) and negative controls (NEGATIVE A--H) across all 40 samples assayed. Positive control probes detect exogenous ERCC control sequences added to the reactions at known concentrations. Negative control probes are not homologous to any known *Smed* sequence and measure background signal. (**C**) Raw counts for the housekeeping genes *ACT-B, RPL-27, G6PD, LUC7L3, clathrin-1, hgp-1, rpl13a, ubiquilin-1* and *zfp207-1* across all 40 experimental samples. *ACT-B* showed significant variation in expression across samples. (**D**) Normalization factors calculated by taking the geometric mean of the positive control sequences POSITIVE A--F (left) or the suite of housekeeping genes (right) across sample replicates. (**E**) Normalized expression trends for *piwi-1*, *H2B,* and *prog-1* during embryogenesis and adulthood (Y, S2--S8, SX, C4) mirror those observed in the single embryo RNA-Seq time course. (**F**) Heat map (left) generated by hierarchical clustering using normalized count data for 108 EEE transcripts across developmental time (Y, S2--S8, SX, C4). Line graphs display expression trends for Clusters 1 (blue), 2 (red), and 4 (green), which corroborate early-embryo-enriched expression observed in the RNA-Seq time course. Transcripts in Clusters 5--8 (n = 9) exhibited low expression throughout the time course and/or exhibited expression trends different from those observed using RNA-Seq.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.051](10.7554/eLife.21052.051)

EEE transcript expression trends during embryonic development and adulthood were validated using the Nanostring nCounter platform ([@bib22]). Total RNA replicates from single S2--S8 embryos, Y, C4 and SX adults were queried for expression of 108 EEE transcripts using a custom probe set (Materials and methods, [Figure 5---source data 2](#SD12-data){ref-type="supplementary-material"}). Curiously, S2 replicates had the lowest summed read counts across the experiment ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}), and expression of *piwi-1*, the cell cycle marker *H2B*, and EEE transcripts was not detected during S2 ([Figure 5](#fig5){ref-type="fig"} -- [Figure 1---figure supplement 1E--F](#fig1s1){ref-type="fig"}, [Figure 5---source data 2](#SD12-data){ref-type="supplementary-material"}), perhaps due to lack of template amplification in the nCounter assays. Apart from the S2 samples, expression trends for *piwi-1*, *H2B*, the pro-differentiation factor *prog-1* and more than 90% of the EEE transcripts mirrored those observed in the RNA-Seq time course ([Figure 5---figure supplement 1E--F](#fig5s1){ref-type="fig"}). Most EEE transcripts queried on the nCounter platform showed peak expression during S3 and/or S4, downregulation during S5, and low to undetectable expression in late stage embryos, C4 or SX adults ([Figure 5---figure supplement 1F](#fig5s1){ref-type="fig"}). Hierarchical clustering using normalized Nanostring count data identified three cohorts of EEE transcripts that hadcomposition and decay kinetics similar to those observed in the RNA-Seq time course; 65% of the EEE transcripts assayed co-clustered in both the RNA-Seqand nCounter analyses ([Figure 5---figure supplement 1F](#fig5s1){ref-type="fig"}).

To determine which cell types express EEE transcripts, and to examine spatiotemporal changes in EEE transcript expression, colorimetric WISH was performed on S2--S8 embryos and intact C4 adults ([Figure 5---source data 3](#SD13-data){ref-type="supplementary-material"}). Some EEE transcripts were expressed exclusively in differentiated temporary embryonic tissues. *VAL-like*, *MPEG1-like-1*, *MPEG1-like-2* and *netrin-like* were solely expressed in the temporary embryonic pharynx until S6, whereas *gelsolin-like* and *4XLIM-like* were expressed in both the primitive ectoderm and temporary embryonic pharynx during S3--S4 ([Figure 5---source data 3](#SD13-data){ref-type="supplementary-material"}, [Figure 1---figure supplements 12C--G](#fig1s12){ref-type="fig"} and [11D--E](#fig1s11){ref-type="fig"}). Expression of these EEE transcripts is likely under zygotic control, occurring during or after the cell fate decisions to downregulate *piwi-1,* exit the cell cycle and differentiate.

Most EEE transcripts queried by WISH (n = 15, 75% assayed) were expressed in both undifferentiated blastomeres and temporary embryonic tissue(s) during S3--S4 ([Figure 5B--E](#fig5){ref-type="fig"}, [Figure 5---source data 3](#SD13-data){ref-type="supplementary-material"}). Some of these transcripts may be maternally deposited, albeit we cannot ascertain the relative contribution(s) of maternal and zygotic expression from our RNA-Seq data. Expression of these EEE transcripts diminished greatly by S5, with EEE transcripts that had been expressed at moderate or low levels becoming undetectable; specific expression of robustly expressed transcripts sometimes persisted until S6 ([Figure 5B--E](#fig5){ref-type="fig"}, [Figure 5---source data 3](#SD13-data){ref-type="supplementary-material"}). Consistent with the RNA-Seq and Nanostring nCounter results, EEE transcript expression was not detected by colorimetric WISH in S7 or S8 embryos or in C4 adults ([Figure 5B--E](#fig5){ref-type="fig"}, [Figure 5---source data 3](#SD13-data){ref-type="supplementary-material"}). Fluorescent double WISH performed with riboprobes complementary to *piwi-1* and the EEE transcripts *tct-like, BTF3-like, DDX5-like* and *eIF4a-like* revealed coincident expression throughout the S4 blastomere compartment ([Figure 5F--I](#fig5){ref-type="fig"}). Intriguingly, EEE transcript expression often decayed quicker in differentiated cells than in undifferentiated blastomeres, raising the possibility that regulation of EEE transcription and/or transcript stability may vary by cell type. Robust expression of many EEE transcripts was detected in blastomeres during S3--S4, EEE transcript expression in temporary embryonic tissues was present during S3 and drastically diminished by S4 ([Figure 5B--E](#fig5){ref-type="fig"}, [Figure 5---source data 3](#SD13-data){ref-type="supplementary-material"}).

EEE transcripts expressed throughout the undifferentiated *piwi-1+* blastomere population in S3--S4 embryos are downregulated as definitive organogenesis begins during S5. These transcripts likely represent a key temporal shift in the expression profile of *piwi-1+* cells during embryogenesis. Moreover, EEE transcript expression provides a molecular metric to distinguish *piwi-1+* blastomeres from adult neoblasts.

Adult lineage progenitors arise within *piwi-1+* blastomeres as organogenesis begins {#s2-5}
------------------------------------------------------------------------------------

Many developmental regulators implicated in lineage commitment and differentiation were expressed at low levels in S2--S4 embryos, and were upregulated dramatically as definitive organogenesis began during S5. Key regulators of cell fate specification for many tissues, including the epidermis (*p53* and zfp-1) ([@bib54]; [@bib78]; [@bib83]), nervous system (*coe, sim, pax3/7 like, lhx1/5--1 *and *pitx*) ([@bib13]; [@bib14]; [@bib43]; [@bib69]), excretory system (*pou2/3, six1/2--2, eya, sal1 *and* osr*) ([@bib70]), photoreceptor neurons (*eya, six-1/2*, *otxA *and *soxB)*, pigment cup cells (*eya, six-1/2*, *sp6-9 *and *dlx)* ([@bib38], [@bib39]) and primordial germ cells (*nos*) ([@bib85]) were among the S5- and/or S6-enriched transcripts ([Figure 1---source data 5](#SD5-data){ref-type="supplementary-material"}--[6](#SD6-data){ref-type="supplementary-material"}). Additional validated or putative drivers of cell fate determination in muscle (*myoD*) ([@bib13]; [@bib69]), the gastrovascular system (*prox-1 *and *foxA1*) ([@bib1]; [@bib69]; [@bib78]), nervous system (*lhx2/9, six3-1, nkx6-like, otxB-like, otxA, pax6a* and *pax6b*) ([@bib55]; [@bib69]) and eyes (*ovo*) ([@bib39]) showed statistically significant upregulation during S5 and/or S6, albeit with adjusted p-values and fold-changes above the stringent thresholds set for inclusion in the S5--S6-enriched transcript lists. GO analysis on S5-enriched transcripts showed statistically significant enrichment of terms associated with patterning and cell fate specification, transcriptional regulation, and development of organ systems including the epidermis, central and peripheral nervous system, muscle, digestive and excretory systems ([Figure 1---source data 5](#SD5-data){ref-type="supplementary-material"}). Taken together, these observations suggest that formation of many definitive organ systems begins during S5, a supposition bolstered by WISH developmental time course data depicting expression patterns for numerous progenitor and cell type-specific markers during embryogenesis (**[Figure 1---source data 9](#SD9-data){ref-type="supplementary-material"}, [Figure 1---figure supplements 13](#fig1s13){ref-type="fig"}--[19](#fig1s19){ref-type="fig"}**).

Adult asexual knockdown phenotypes for many developmental TFs upregulated during S5 and S6 suggest that these genes are required for lineage specification, tissue maintenance, and production of new tissue during regeneration, with correspondence between affected tissues and site(s) of expression. Heterogeneous expression of TFs in neoblasts and post-mitotic progenitors informed the hypothesis that the neoblast population contains pluripotent stem cells as well as cycling, lineage-primed progenitors ([@bib59]). Single cell sequencing (SCS) studies suggest that the zeta (ζ) and gamma (γ) neoblast subclasses are epidermal and gut progenitors, respectively ([@bib78]; [@bib88]), while the sigma (σ) neoblast subclass likely contains both pluripotent stem cells and progenitors for other lineages, including neural subtypes, protonephridia and primordial germ cells ([@bib78]). In practice, coexpression of pan-neoblast markers (e.g., *piwi-1*) and developmental TFs is used for neoblast subclass identification.

*Smed* embryos are wholly reliant on cycling *piwi-1+* cells for creation of new tissues, and heterogeneous expression of key developmental TFs within *piwi-1+* blastomeres is predicted to generate the diverse array of progenitors required for organogenesis. While only a small fraction of the *piwi-1+* compartment is predicted to be double positive for any given lineage marker, the entire population of lineage-positive cells is predicted to be positive for *piwi-1* at its inception. As development proceeds, the fraction of lineage-positive cells coexpressing *piwi-1* will decrease as cells downregulate expression of *piwi-1* and differentiate further.

If parallels with neoblasts hold true, then *piwi-1+* blastomeres should self-renew and give rise to differentiating progeny during S5. To assay for cells exiting the *piwi-1+* compartment during S5, embryos were costained with *piwi-1* riboprobes and PIWI-1 antibodies. In adults, *piwi-1* mRNA is restricted to the neoblast population, whereas PIWI-1 protein perdures in early post-mitotic progeny ([@bib26]; [@bib70]; [@bib84]). Indeed, recent work suggests that mechanisms exist to sequester *piwi-1* mRNA and chromatoid bodies within one daughter cell during neoblast division, producing one cell that maintains neoblast identity and one cell that differentiates ([@bib41]). Virtually all S5 *piwi-1+* blastomeres also contained PIWI-1 protein ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Rare cells positive for PIWI-1 protein but in which *piwi-1* mRNA was undetectable were observed in S5 embryos, suggesting that some of the division progeny exited the *piwi-1+* blastomere population ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}).

To address whether lineages required for organogenesis arise within *piwi-1+* blastomeres during S5, expression of four evolutionarily conserved TFs implicated in tissue differentiation across three germ layers was examined singly and in combination with *piwi-1. p53* and *pax6a,* regulators of epidermal and neural fates, respectively, were proxies for ectodermal derivatives. Populations expressing *myoD*, a master regulator of muscle fate, were considered mesodermal derivatives, and populations expressing *gata456a*, a regulator of gut development, represented endodermal derivatives. While expression of these TFs was occasionally detected in a small number of cells during S4, robust expression of *p53* ([Figure 1---figure supplement 15B](#fig1s15){ref-type="fig"}), *gata456a* ([Figure 1---figure supplement 13F](#fig1s13){ref-type="fig"}), *myoD* ([Figure 1---figure supplement 17A](#fig1s17){ref-type="fig"}) and *pax6a* ([Figure 1---figure supplement 16B](#fig1s16){ref-type="fig"}) manifest in scattered parenchymal cells during S5. Indeed, fluorescent double WISH with *piwi-1* and *p53, gata456a, myoD* or *pax6a* identified prospective epidermal, gut, muscle and neural progenitor populations that coexpressed *piwi-1* and the developmental TFs in S5 embryos, as well as single positive populations for all of the markers assayed ([Figure 6A--D](#fig6){ref-type="fig"}, [Videos 11](#media11){ref-type="other"}--[14](#media14){ref-type="other"}).10.7554/eLife.21052.052Figure 6.Adult lineages arise within the *piwi-1+* blastomere population as organogenesis begins.(**A**--**D**) Developmental transcription factors implicated in tissue specific differentiation programs are expressed in subpopulations of *piwi-1+* cells during S5. Fluorescent WISH with *piwi-1* (red) and *p53* (**A**), *gata456a* (**B**), *myoD* (**C**) and *pax6a* (**D**) (green) riboprobes on S5 embryos. Embryos in (B-D) were costained with *VAL-*like, a temporary embryonic pharynx specific marker (also in red). Right: Venn diagrams depict percentages of cells that were single or double positive for *piwi-1* and the indicated TFs. Scale bars: 100 µm. (**E**--**G**) Hierarchical clustering of zeta (ζ, **E**), gamma (γ, **F**) and sigma (σ, **G**) neoblast subclass-enriched transcripts during embryogenesis (Y and S2--S8), and in asexual (C4) and virgin sexual (SX) adults.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.052](10.7554/eLife.21052.052)10.7554/eLife.21052.053Figure 6---source data 1.Behavior of ζ, γ and σ adult asexual neoblast subclass-enriched transcripts during embryogenesis.Hierarchical clustering of Zeta (ζ) , Gamma (γ) and Sigma (σ) subclass transcripts was performed using normalized RPKM data from the single embryo RNA-Seq developmental time course. Average RPKM values for Y, S2--S8 embryos and for C4 and SX adults are included. Transcripts with enriched at one or more embryonic stages are flagged.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.053](10.7554/eLife.21052.053)10.7554/eLife.21052.054Figure 6---figure supplement 1.PIWI-1 protein may perdure in cells committed to differentiation.(**A**) Fluorescent WISH costaining on S5 embryos using riboprobes against *piwi-1* (red) and antibodies against PIWI-1 protein (green). Cyan arrows: single positive cells for which PIWI-1 protein, but not *piwi-1* mRNA, was detected. Scale bar: 100 µm. 99 ± 0.4% *piwi-1+* cells were double positive for PIWI-1 protein, n = 4,152 *piwi-1+* cells scored. 96 ± 3.1% PIWI-1 positive cells were double positive for *piwi-1* mRNA, n = 4,296 PIWI-1+ cells scored. n = 4 S5 embryos.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.054](10.7554/eLife.21052.054)Video 11.Definitive epidermal progenitors arise in the *piwi-1+* blastomere population during S5.SPIM -reconstructed S5 embryo costained with *piwi-1* (red) and *p53* (green). Definitive epidermal progenitors, coexpressing *piwi-1* and *p53*, are dispersed in the embryonic wall. As definitive epidermal progenitors differentiate, they are predicted to downregulate *piwi-1* and to retain expression of *p53.***DOI:** [http://dx.doi.org/10.7554/eLife.21052.055](10.7554/eLife.21052.055)10.7554/eLife.21052.055Video 12.Definitive gut progenitors arise in the *piwi-1+* blastomere population during S5.SPIM reconstructed S5 embryo costained with *piwi-1* and *VAL-like* (both in red) and *gata456a* (green). Definitive gut progenitors, coexpressing *piwi-1* and *gata456a,* are dispersed in the embryonic wall. As definitive gut progenitors differentiate, they are predicted to downregulate *piwi-*1 and to retain expression of *gata456a. VAL-like* is expressed the temporary embryonic pharynx and is not detected in *piwi-1+* blastomeres.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.056](10.7554/eLife.21052.056)10.7554/eLife.21052.056Video 13.Muscle progenitors arise in the *piwi-1+* blastomere population during S5.SPIM reconstructed S5 embryo costained with *piwi-1* and *VAL-like* (both in red) and *myoD* (green). Muscle progenitors, coexpressing *piwi-1* and *myoD,* are dispersed in the embryonic wall. As muscle progenitors differentiate, they are predicted to downregulate *piwi-*1 and to retain expression of *myoD. VAL-like* is expressed the temporary embryonic pharynx and is not detected in *piwi-1+* blastomeres.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.057](10.7554/eLife.21052.057)10.7554/eLife.21052.057Video 14.Neural progenitors arise in the *piwi-1+* blastomere population during S5.SPIM reconstructed S5 embryo costained with *piwi-1* and *VAL-like* (both in red) and *pax6a* (green). Neural progenitors, coexpressing *piwi-1* and *pax6a,* are dispersed in the embryonic wall. As neural progenitors differentiate, they are predicted to downregulate *piwi-*1 and to retain expression of *pax6a. VAL-like* is expressed the temporary embryonic pharynx and is not detected in *piwi-1+* blastomeres.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.058](10.7554/eLife.21052.058)10.7554/eLife.21052.058

The advent of developmental TF expression within *piwi-1+* blastomeres during S5, coupled with downregulation of EEE transcripts, may signal the emergence of molecularly distinct subpopulations akin to the neoblast subclasses. Whole embryo expression trends for EEE, σ, γ and ζ class transcripts suggest that large scale, cell-intrinsic shifts in gene expression occur within blastomeres between S4 and S5. Moreover, the developmental output of *piwi-1+* blastomeres, as described by molecular fate mapping, diversifies greatly during S5 and S6.

The expression signatures of the ζ and γ neoblast subclasses emerge during S5. ζ neoblasts require *p53* and *zfp-1* activities for production of post-mitotic mesenchymal progenitors, which simultaneously differentiate, migrate and ultimately integrate into the epidermis during homeostasis ([@bib78]). *p53*, *zfp-1*, *tcf15*, *sox-P3*, *fgfr1*, *egr-1*, *six6\**, *gata123\** ([@bib78]) and 15 additional transcripts used as classifiers of ζ subgroup identity in SCS experiments ([@bib88]) displayed statistically significant upregulation in whole embryos during S5 or later developmental stages ([Figure 6E](#fig6){ref-type="fig"}, [Figure 6---source data 1](#SD14-data){ref-type="supplementary-material"}, [Figure 1---figure supplement 15A](#fig1s15){ref-type="fig"}, [Figure 1---source data 5](#SD5-data){ref-type="supplementary-material"}--[8](#SD8-data){ref-type="supplementary-material"}). Furthermore, the ζ neoblast transcripts *soxP3, egr-1*, *fgfr1* and *prog-1* clustered together in the analysis of adult asexual neoblast-enriched transcripts, indicating that they displayed similar expression profiles during embryogenesis ([Figure 4A](#fig4){ref-type="fig"}, [Figure 4---source data 1](#SD10-data){ref-type="supplementary-material"}). Transcripts specifically expressed in post-mitotic epidermal progenitors downstream of ζ neoblasts, including *prog-1*, *AGAT-1* and *zpuf-6*, were enriched and first detected by WISH during S5 ([Figure 1---figure supplement 15C,E--G](#fig1s15){ref-type="fig"}, [Figure 1---source data 5](#SD5-data){ref-type="supplementary-material"}). γ neoblasts are identified by enriched expression of *gata456a*, *hnf4*, *prox-1* and *nkx2.2\** ([@bib78]; [@bib84]). *prox-1* and *nkx2.2* were expressed at low levels in S2--S4 embryos and showed statistically significant upregulation during S5, and 15 additional γ neoblast-enriched transcripts identified in SCS experiments were enriched during S5 or later in development ([Figure 6F](#fig6){ref-type="fig"}, [Figure 6---source data 1](#SD14-data){ref-type="supplementary-material"}, [Figure 1---figure supplement 13E](#fig1s13){ref-type="fig"}, [Figure 1---source data 5](#SD5-data){ref-type="supplementary-material"}--[8](#SD8-data){ref-type="supplementary-material"}). The molecular staging series detected expression of *gata456a* and *hnf4* in yolk and early embryos (S2--S4) ([Figure 6F](#fig6){ref-type="fig"}). However, *gata456a* and *hnf4* expression were solely detected in the embryo proper by WISH, first in the developing temporary embryonic pharynx during S2 and later in parenchymal cells during S5 ([Figure 1---figure supplement 13F--G](#fig1s13){ref-type="fig"}).

Charting the emergence of the σ neoblast subclass is hampered by limitations of the subclass designation: σ neoblasts are presumed to be an amalgamation of several progenitor populations and pluripotent stem cells. Several σ -class genes, notably *SoxP-1* and *SoxP-2*, were expressed in parenchymal cells throughout embryogenesis, similar to *piwi-1* ([Figure 4A](#fig4){ref-type="fig"}, [Figure 4---source data 1](#SD10-data){ref-type="supplementary-material"}, [Figure 4---figure supplement 1A--C](#fig4s1){ref-type="fig"}, [Figure 6---source data 1](#SD14-data){ref-type="supplementary-material"}). *SoxP-1* is required for neoblast maintenance ([@bib83]), suggesting that σ-class transcripts with expression profiles to *SoxP-1* and *SoxP-2* during embryogenesis may also be expressed in pluripotent neoblasts. In contrast, lineage-primed progenitor factions within the σ subclass probably arise during S5. Genes with functions in tissue-specific differentiation programs, including *soxB1* ([@bib39]; [@bib45]), *pou2-3* ([@bib70]), *nos* ([@bib85]), *pitx* ([@bib14]; [@bib43]), *sim* ([@bib13]), and *smad6/7--1* ([@bib24]) were expressed at low levels in S2--S4 embryos and were upregulated during S5 ([Figure 6G](#fig6){ref-type="fig"}, [Figure 6---source data 1](#SD14-data){ref-type="supplementary-material"}, [Figure 1---source data 5](#SD5-data){ref-type="supplementary-material"}).

The gene expression signature of the adult neoblast compartment is an emergent property of the *piwi-1+* population during embryogenesis. First, EEE transcripts are uniquely associated with the expression signature(s) of undifferentiated *piwi-1+* blastomeres in early embryos. Second, adult neoblast subclasses arise as lineages are born within *piwi-1+* blastomeres during S5. Molecular heterogeneity within the neoblast compartment is largely attributed to the diverse array of lineage-dedicated progenitors within the population, a hypothesis supported by our finding that subclass marker expression was dramatically upregulated as organogenesis began. Progenitor subpopulations required for organ formation during embryogenesis persist into adulthood, where steady-state output from different lineages maintains tissue homeostasis. At present, we cannot distinguish whether lineages perpetually re-emerge due to asymmetric division of pluripotent stem cells, or whether progenitor populations established during embryogenesis are maintained by self-renewal. These observations beg the question: do *piwi-1+* cells behave similarly to neoblasts throughout embryogenesis? Or alternatively, is neoblast activity an acquired feature that emerges in tandem with the adult molecular expression signature?

Embryos undergoing organogenesis contain cells with cNeoblast activity {#s2-6}
----------------------------------------------------------------------

Neoblasts are completely and irreversibly eliminated following treatment with 6,000 Rads ([@bib58]; [@bib84]), causing irradiation sickness and ultimately death. Transplantation of wildtype adult tissue grafts or cell suspensions into lethally irradiated adult hosts that are devoid of stem cells results in engraftment and expansion of donor-derived *piwi-1+* cells, production of differentiated progeny, reconstitution of the neoblast compartment and rescue from lethality ([@bib5]; [@bib25]; [@bib78]; [@bib84]). *piwi-1+* cells that form pluripotent, expanding colonies following sublethal irradiation or transplantation into a lethally irradiated host are called clonogenic neoblasts (cNeoblasts) ([@bib84]). cNeoblasts are predicted to have a widespread distribution in the parenchyma, and this population contains within it the most primitive stem cells. At present, the operational definition for cNeoblast exists apart from the gene expression signatures for the neoblast subclasses; cNeoblasts are likely contained within, but may not be exclusive to, the σ class.

To assess whether *Smed* embryos harbor *piwi-1+* cells with cNeoblast activity, heterochronic, heterotopic transplantations were performed. S4, S5, S6, S7 and S8 embryonic cell suspensions were injected into the tail parenchyma of lethally irradiated sexual adult hosts at 3 days post-irradiation (dpi) ([Figure 7A](#fig7){ref-type="fig"}, Materials and Methods). To determine whether comparable numbers of *piwi-1+* cells were introduced per host for the developmental stages assayed, transplanted hosts were fixed at 1 hr post-transplant (hpt) and stained with *piwi-1* riboprobes. More than 85% of S4--S8 transplants fixed at 1 hpt contained *piwi-1+* cell(s) in the tail parenchyma, suggesting that the cell injection technique was robust and reliable ([Figure 7B](#fig7){ref-type="fig"}). S5, S6, S7 and S8 transplants contained comparable numbers of *piwi-1+* cells per host at 1 hpt, while significantly fewer *piwi-1+* cells were introduced per S4 embryonic cell transplant ([Figure 7C,F](#fig7){ref-type="fig"}).10.7554/eLife.21052.059Figure 7.Embryonic cells acquire the ability to engraft, persist and proliferate in an adult microenvironment as organogenesis proceeds.(**A**) Schematic depicting the workflow for heterochronic transplantation experiments. S4, S5, S6, S7 or S8 embryonic cell suspensions were injected into the tails of lethally irradiated sexual adult hosts at 3 days post-irradiation (dpi). Cohorts of transplanted animals were fixed at 1 hr and 5 days post-transplantation (1 hpt and 5 dpt, respectively) for staining with *piwi-1* riboprobes and H3S10p antibodies. Lethally irradiated, uninjected host controls were fixed and stained at 5 dpt. (**B**) Percentage of transplanted animals fixed at 1 hpt (blue bars) or 5 dpt (red bars) containing one or more donor-derived *piwi-1+* cell(s). X-axis: stage (S) of donor cells. (**C**) Number of donor-derived *piwi-1+* cell(s) per transplant at 1 hpt and 5 dpt. Each point represents one transplanted animal. Mean ± standard deviation (black bars) are shown. Statistical tests were performed using a generalized linear model, assuming that the counts followed a Poisson distribution. S4 transplants contained significantly fewer *piwi-1+* cells at 1 hpt than S5, S6, S7 or S8 transplants (Tukey post-hoc comparisons, S4 vs S5, S4 vs S6 and S4 vs S7, S4 vs S8: p\<0.001). Group differences in the number of *piwi-1+* cells at 1 hpt for S5 and S6 transplants were not statistically significant (p=0.21). Significantly fewer S4 and S5 donor-derived *piwi-1+* cells persisted at 5 dpt than were observed for later stages (Tukey post-hoc comparisons: S4 vs S5, S4 vs S6, S4 vs S7 and S4 vs S8: p\<0.001. S5 vs S6, S5 vs S7, S5 vs S8: p\<0.001). (**D**) Percentage of transplants with mitotic *piwi-1+* cell(s) at 5 dpt (green bars). X-axis: Donor cell stage. (**E**) Mitotic index for donor-derived *piwi-1+* cells at 5 dpt. Stage-specific differences were not observed for S4--S8 embryonic cell populations using a generalized linear model, assuming counts followed a Poisson distribution and the number of *piwi-1+* cells as a covariate. (**B**--**E**) Numbers of transplants scored: S4: n = 36 (1 hpt), n = 43 (5 dpt), four independent experiments. S5: n = 15 (1 hpt), n = 16 (5 dpt), two independent experiments. S6: n = 31 (1 hpt), n = 29 (5 dpt), four independent experiments. S7: n = 31 (1 hpt), n = 30 (5 dpt), four independent experiments. S8: n = 19 (1 hpt), n = 20 (5 dpt), three independent experiments. (**F**) Confocal maximal projections of S4, S5, S6, S7 and S8 embryonic cell transplants fixed at 1 hpt and 5 dpt. Animals were stained with *piwi-1* riboprobes (green), antibodies against the mitotic marker H3S10p (red, 5 dpt only) and DAPI nuclear counterstain (blue). S6, S7 and S8 insets: mitotic *piwi-1+* cells. Red arrows indicate mitotic cells magnified in insets. Yellow arrows: mitotic *piwi-1+* cells. Scale bar (inset): 20 µm. Scale bar (panel): 100 µm. (**B**--**C**) S4--S8 embryonic *piwi-1+* cells were reliably introduced into hosts. S6--S8 embryonic *piwi-1+* cells persisted in an adult microenvironment. (**D**-**E**) S6--S8 embryonic *piwi-1+* cells proliferated in an adult microenvironment.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.059](10.7554/eLife.21052.059)

To assay whether embryonic *piwi-1+* cells persisted and proliferated in an adult microenvironment, cohorts of transplanted animals and lethally irradiated uninjected hosts were fixed at 5 days post-transplantation (dpt) and stained with *piwi-1* riboprobes and H3S10p antibodies ([Figure 7B--F](#fig7){ref-type="fig"}). Persistent *piwi-1+* cells from S6, S7 and S8 embryos were observed in the vast majority of transplants scored at 5 dpt ([Figure 7B](#fig7){ref-type="fig"}), and no statistically significant difference among stages was detected in the mean number of *piwi-1+* cells present per host ([Figure 7C](#fig7){ref-type="fig"}). Moreover, most S6, S7 and S8 embryonic donor cell transplants contained dividing *piwi-1+* cell(s) at 5 dpt ([Figure 7D--F](#fig7){ref-type="fig"}), and no statistically significant difference among stages was detected in the mitotic index of donor-derived *piwi-1+* cells per host at 5 dpt ([Figure 7E](#fig7){ref-type="fig"}). In contrast, S4 and S5 embryonic *piwi-1+* cells were significantly less likely to persist in adult hosts at 5 dpt than were S6, S7 or S8 embryonic *piwi-1+* cells ([Figure 7B--C](#fig7){ref-type="fig"}). Persistent S4 derived *piwi-1+* cells were rarely observed at 5 dpt, and cell division was not observed ([Figure 7D--E](#fig7){ref-type="fig"}). As expected, *piwi-1+* cells were never observed in uninjected lethally irradiated hosts (n = 82 hosts scored at 3 dpi).

Fewer S5 embryonic cell transplants contained persistent *piwi-1+* cells at 5 dpt ([Figure 7B](#fig7){ref-type="fig"}), and the number of S5 derived *piwi-1+* cells per host at 5 dpt was significantly lower than for later stages ([Figure 7C](#fig7){ref-type="fig"}). Similarly, the fraction of S5 embryonic cell transplants containing mitotic *piwi-1+* cell(s) was reduced relative to S6 and later stages ([Figure 7D](#fig7){ref-type="fig"}). The reduced persistence of S4 and S5 derived *piwi-1+* cells in an adult microenvironment was probably not attributable to technical variability or to the absolute number of embryonic *piwi-1+* cells introduced per host, since comparable numbers of S5, S6, S7 and S8 *piwi-1+* cells were introduced per transplant ([Figure 7C](#fig7){ref-type="fig"}). Stage-specific, cell autonomous factors likely underlie the starkly different responses of S5 and S6 embryonic cells following transplantation into the adult parenchyma. These results suggest that S4 and S5 *piwi-1+* blastomeres are functionally distinct from *piwi-1+* cells present at S6 and later stages. *piwi-1+* blastomeres acquire competency to engraft and respond appropriately to adult environmental cues as development proceeds during S5.

To assess whether embryos undergoing organogenesis harbor cells capable of rescuing and reconstituting lethally irradiated adult hosts, S5, S6, S7 and S8 embryonic cell suspensions were injected into lethally irradiated sexual adult hosts at 1 dpi ([Figure 8A](#fig8){ref-type="fig"}, Materials and methods). Consistent with previous results, persistent *piwi-1+* cells from S6, S7 and S8 embryos were observed in the vast majority of samples scored at 5 dpt ([Figure 8B](#fig8){ref-type="fig"}), and no statistically significant difference was detected in either the mean number or the mitotic index of *piwi-1+* donor-derived cells per host at 5 dpt ([Figure 8C--D](#fig8){ref-type="fig"}). Likewise, donor-derived *piwi-1+* cells from S5 embryos were far less likely to persist and divide in adult hosts ([Figure 8B--D](#fig8){ref-type="fig"}). As expected, *piwi-1+* cells were never observed in uninjected lethally irradiated hosts (n = 81 hosts scored at 6 dpi).10.7554/eLife.21052.060Figure 8.Embryos undergoing organogenesis contain cNeoblasts.(**A**) Schematic for heterochronic transplantation experiments. S5, S6, S7 or S8 embryonic cell suspensions were injected into the tail parenchyma of lethally irradiated sexual adult hosts at 1 day post irradiation (dpi). Cohorts of transplanted animals and uninjected host controls were fixed at 5 days post-transplantation (dpt) for staining with *piwi-1* riboprobes and H3S10p antibodies. The remaining animals were monitored for 70 dpt for survival and rescue. (**B**) Percentage of transplants with persistent, donor-derived *piwi-1+* cell(s) (blue) or donor-derived mitotic (*piwi-1+*, H3S10p+) cell(s) (red) at 5 dpt. X-axis: Embryonic donor cell stage. (**C**) Number of *piwi-1+* cells per transplanted host at 5 dpt for S5--S8 embryonic cell transplants. Each point represents one transplanted animal. Means ± standard deviation (SD) are shown (black bars). Statistically significant differences in the number of persistent *piwi-1+* cells per transplant at 5 dpt were observed using a generalized linear model, assuming that count data followed a Poisson distribution. S5 transplants contained fewer persistent *piwi-1+* cells than S6 or S7 transplants (Tukey post-hoc comparisons, S5 vs S6: p\<0.0001, S5 vs S7: p\<0.0001, S5 vs S8: p\<0.0001). (**D**) Mitotic index for donor-derived *piwi-1+* cells at 5 dpt for S5--S8 embryonic cell transplants. Each point represents one transplanted animal. Means ± standard deviation (SD) are shown (black bars). Statistically significant differences in the *piwi-1+* cell mitotic index were observed using a generalized linear model with *piwi-1+* cell counts as a covariate, assuming that count data followed a Poisson distribution. S5 transplants contained significantly fewer cycling cells than S6, S7 or S8 transplants (Tukey post-hoc comparisons, S5 vs S6: p\<0.01, S5 vs S7: p\<0.01, S5 vs S8: p\<0.001). (**E**) Confocal maximal projections for S5, S6, S7 and S8 embryonic cell transplants fixed at 5 dpt and stained with *piwi-1* riboprobes (green), H3S10p antibodies (red) and DAPI (blue). S6, S7 and S8 insets show mitotic *piwi-1+* cells. Red arrows indicate mitotic cells magnified in the insets. Yellow arrows: mitotic *piwi-1+* cells. Scale bar (inset): 20 µm. Scale bar (panel): 100 µm. (**B**--**E**) Numbers of transplants scored in four independent experiments: S5 n = 22; S6 n = 24; S7 n = 21; S8 n = 27 in (**C**), n = 21 in (**D**). (**F**) Survival curves for S5, S6, S7 and S8 embryonic cell transplants and uninjected 6,000-Rad-irradiated host controls as a function of time (days) post-transplant. (**G**) Live images of regenerating S6, S7 and S8 rescue animals. Left: Tail fragment after self-amputation of head and trunk tissue. Middle: Tail fragment with unpigmented anterior blastema (yellow arrowheads). Right: Animal with new head tissue and developing eyes (yellow arrows) and a regenerated pharynx (yellow asterisk). Animals from different experiments are shown in the S7 panels; the same animals are shown in the S6 and S8 panels. Dorsal view. Anterior: top. Scale: 100 µm. (**F**--**G**) Numbers of transplants scored in four independent experiments: host controls n = 89; S5 n = 105; S6 n = 90; S7 n = 92; S8 n = 85. Rescue animals were obtained in two experiments for S6 and S7 transplants, and four experiments for S8 transplants. (**B**--**E**) S6, S7 and S8 embryonic donor cells persist and divide in the adult parenchyma. (**F**--**G**) S6, S7 and S8 embryonic cells can rescue lethally irradiated adult hosts.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.060](10.7554/eLife.21052.060)10.7554/eLife.21052.061Figure 8---figure supplement 1.Progression of irradiation-induced phenotypes, rescue or death for heterochronic transplantation assays.(**A**--**E**) Stacked bar graphs depicting the percentage of S5 (**A**), S6 (**B**), S7 (**C**) and S8 (**D**) transplanted animals or uninjected, 6,000-Rad-irradiated hosts (**E**) that displayed no visible phenotype (blue), head regression (red), head and tail regression (yellow), head regression and pharynx lesions (green), head regression and ventral curling (purple), death (gray) or rescue (the development of an anterior blastema and ensuing regeneration of the host animal) (orange). Bulk cell transplantation was performed as described in [Figure 8A](#fig8){ref-type="fig"} and the Materials and methods. Transplanted animals and uninjected controls were monitored for 70 days post-irradiation (dpi). S5 transplants: n = 105 animals. S6 transplants: n = 90 animals. S7 transplants: n = 92 animals. S8 transplants: n = 85 animals. Uninjected sexual adult hosts: n = 89 animals. Results were tallied from four independent experiments for each embryonic stage assayed.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.061](10.7554/eLife.21052.061)

Survival of S5--S8 transplants and host controls was monitored for 70 dpt (*i.e.,* 71 dpi). Worms were scored for irradiation-induced phenotypes, including head and tail regression, lesion formation, ventral curling and death. Rescue, anterior blastema formation and subsequent regeneration of an entire individual from injected tail fragment, was also scored ([@bib25]; [@bib84]) ([Figure 8F--G](#fig8){ref-type="fig"}, [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). Irradiation-induced phenotypes manifest in control and transplanted individuals alike between 7--14 dpt (*i.e.,* 8--15 dpi) ([Figure 8---figure supplement 1A--E](#fig8s1){ref-type="fig"}), and none of the controls survived long-term ([Figure 8F](#fig8){ref-type="fig"}, [Figure 8---figure supplement 1E](#fig8s1){ref-type="fig"}). Remarkably S6, S7 and S8 embryonic donor cells were capable of rescuing lethally irradiated adult hosts ([Figure 8F--G](#fig8){ref-type="fig"}). Rescued animals underwent complete head regression, self-amputation posterior to the pharynx, and tail fragments that formed anterior blastemas which promoted regeneration of individuals containing two visible eyes, a central pharynx and triclad gut ([Figure 8F--G](#fig8){ref-type="fig"}, [Figure 8---figure supplement 1B--D](#fig8s1){ref-type="fig"}). None of the S5 embryonic cell recipients mounted a rescue response ([Figure 8F](#fig8){ref-type="fig"}, [Figure 8---figure supplement 1A](#fig8s1){ref-type="fig"}). The rescue assay results suggest that S6, S7 and S8 embryos harbor cNeoblasts, cells that are capable of self-renewing and producing the diverse array of cell types required for whole animal regeneration.

Taken together, stage-dependent molecular and functional distinctions exist among *piwi-1+* blastomeres before and after organogenesis begins. S4 *piwi-1+* cells, which express EEE and adult asexual neoblast enriched transcripts, are largely incapable of persisting and dividing in an adult microenvironment ([Figure 7B--C](#fig7){ref-type="fig"}). During S5, as dramatic shifts in gene expression occur, *piwi-1+* cells become competent to persist and proliferate in the adult parenchyma ([Figures 7B--C](#fig7){ref-type="fig"} and [8B--D](#fig8){ref-type="fig"}). We propose that cNeoblasts arise during S5. Heterochronic transplantation experiments revealed that S6, S7 and S8 embryos possess cells that behaved similarly to adult cNeoblasts: they consistently engrafted into adult hosts, proliferated and were ultimately capable of mounting a rescue response ([Figure 8B--G](#fig8){ref-type="fig"}). Acquisition of cNeoblast activity during embryogenesis correlates temporally with large-scale changes in gene expression observed at the outset of organogenesis, suggesting that pluripotent stem cells and lineage-primed progenitors first emerge during S5 ([Figure 9](#fig9){ref-type="fig"}). The ontogeny of the adult neoblast compartment can therefore be traced back to the *piwi-1+* zygote, which gives rise to anarchic, cycling *piwi-1+* blastomeres, some of which persist in the S3--S4 embryonic wall and establish pluripotent neoblasts and progenitor subpopulations during S5. The remarkable developmental plasticity of adult planarians is likely due to the singular ability of neoblasts to perpetuate and redeploy embryonic developmental programs.10.7554/eLife.21052.062Figure 9.Ontogeny of the adult neoblast compartment.Asynchronously cycling *piwi-1+* cells fuel embryogenesis, giving rise to all temporary and definitive tissues. During S2, some *piwi-1+* blastomeres (purple cells) exit the cell cycle and differentiate into temporary embryonic tissues (primitive ectoderm, temporary embryonic pharynx and primitive endoderm). The remaining *piwi-1+* blastomeres, located in the embryonic wall (purple cells, S3-S4), continue to divide and express both EEE transcripts (turquoise arrow) and adult asexual neoblast enriched transcripts (red arrow). As organogenesis begins during S5, EEE transcripts are downregulated throughout the compartment (purple cells transition into red). Concomitantly, progenitor subpopulations required for definitive organ formation are specified via the heterogeneous expression of developmental transcription factors within the *piwi-1+* population (colored cells denote different progenitor subpopulations). Adult pluripotent neoblasts, themselves a lineage, are established during S5 (red cells). Embryonic donor cells harvested during or after S6 function similarly to adult neoblasts (cNeoblast activity, gray arrow). Pluripotent and lineage-primed neoblasts established during embryogenesis are maintained throughout the lifetime of the animal. Neoblasts are required for tissue maintenance during homeostasis and the formation of new tissue during regeneration.**DOI:** [http://dx.doi.org/10.7554/eLife.21052.062](10.7554/eLife.21052.062)

Discussion {#s3}
==========

Regeneration remains one of the most poorly understood processes in developmental biology. The origin and regulation of cells that make regeneration possible are largely obscure. How similar or distinct developmental processes are during embryogenesis and regeneration remains to be determined. In fact, few experimental systems are available to study these issues systematically. Here, we lay the foundation for the formal comparison of molecular processes and gene functions during embryogenesis and regeneration in *Smed,* an organism uniquely suited to address the relationship between developmental plasticity and regeneration competency.

*S. mediterranea*: a developmental system for comparative studies of embryogenesis and regeneration {#s3-1}
---------------------------------------------------------------------------------------------------

To identify similarities and key differences between embryogenesis and regeneration, careful consideration must be given to distinctions in context, chronology, scope and type of regeneration (homeostatic or facultative), and to the ontogeny of effector cell type(s). Which aspects of embryonic development are recapitulated during regeneration, and which are context-specific? What factors influence the competency and extent of regenerative responses, and do these factors have embryonic origins? The workhorses of modern developmental biology, *C. elegans*, *D. melanogaster*, *D. rerio*, and *M. musculus* have limited, if any, regenerative potential during adulthood, precluding or severely limiting comparative inquiries. In contrast, *Smed* adults exhibit robust homeostatic and facultative regenerative potential, both neoblast-dependent phenomena that have largely been studied using a clonal, asexually reproducing strain. Neither descriptive nor functional studies of *Smed* embryogenesis have been reported.

We generated two foundational resources: a molecular staging series for *Smed* embryogenesis and an expression atlas describing temporary and definitive organ development. To investigate the embryonic origins of regeneration, we provide an ontogeny for the adult neoblast compartment. The molecular staging series facilitated the identification of embryonic predecessors of adult neoblast lineages and the developmental transition when neoblast specification occurs. Adult neoblast lineages, including pluripotent stem cells and lineage-primed progenitors, are established as definitive organogenesis begins. Neoblast lineages, required for organ formation during embryogenesis, persist into adulthood, where they are redeployed for homeostatic maintenance of all differentiated tissues, including the germline, and formation of missing tissues during regeneration. Moving forward, investigation of neoblast dynamics, particularly the regulation of self-renewal and commitment to differentiation, will be a central, unifying feature of comparative studies on organ formation, maintenance, repair and replacement.

Deciphering the origin and identity of neoblasts, agents of development, tissue homeostasis and regeneration {#s3-2}
------------------------------------------------------------------------------------------------------------

Unraveling the molecular mechanism of neoblast specification during embryogenesis will provide insight into the identity of adult pluripotent stem cells indispensible for homeostatic and facultative regeneration in planarians. Intensive efforts to define the term neoblast, and to characterize the presumed plurality of cell types within the asexual adult neoblast population, have generated numerous, unreconciled molecular and functional criteria. At present, gene expression signatures for neoblast subpopulations cannot be correlated with functional distinctions (should they exist) in self-renewal, pluripotency or cell fate restriction. It is not known whether hierarchical relationships exist between pluripotent cells and progenitors, whether cycling progenitors can dedifferentiate and/or interconvert, how stable subpopulations are over time, or when and how progenitors make an irreversible commitment to differentiation. Furthermore, preferred usage of *Smed* C4 asexual animals to classify and examine relationships among subpopulations precludes comprehensive examination of the lineage repertoire.

The expression of pluripotency factors is probably necessary, but not sufficient, for the assumption of neoblast fate. We report that many genes known to regulate adult asexual neoblast self-renewal and maintenance were expressed throughout embryogenesis, and showed that several of these genes were expressed throughout S3--S5 *piwi-1+* blastomeres. Functional differences between blastomeres and neoblasts were observed in heterochronic, heterotopic transplantation experiments. S4 and S5 embryonic donor cells were far less likely to persist and proliferate in stem cell deficient adult hosts than were embryonic donor cells harvested during S6 or later. Moreover, S5 embryonic donor cells did not rescue lethally irradiated hosts, whereas S6--S8 embryonic donor cells functioned like adult neoblasts and were capable of rescue. These results suggest that neoblast specification occurs during S5, and highlight the importance of cell-intrinsic changes in the blastomere to neoblast transition.

Differences in transplanted cell behavior correlated with large-scale changes in gene expression as definitive organogenesis began. EEE transcripts, uniquely expressed in blastomeres, are attractive candidates for repressors of neoblast fate, and/or effectors of molecular changes in blastomeres that are necessary for acquisition of neoblast fate. It is not known whether EEE transcript downregulation in blastomeres is necessary for neoblast specification, or whether expression of EEE transcripts and developmental TFs required for lineage specification are mutually exclusive. Further studies will determine whether and how maternal factors influence the early stages of *Smed* embryogenesis. Which EEE transcripts are maternally deposited, and which mechanisms effect maternal transcript degradation? When do wave(s) of zygotic genome activation occur, and how does zygotic genome activation in blastomeres relate to cell differentiation and neoblast specification? Additional factors, such as changes in chromatin state, may also correlate with or play a causative role in the blastomere to neoblast transition.

The paradox of pattern formation: robustness of an anarchic, self-organizing system and its implications for understanding regeneration {#s3-3}
---------------------------------------------------------------------------------------------------------------------------------------

Ectolecithal development and dispersed cleavage pose unique developmental challenges, making *Smed* embryogenesis a novel paradigm for regulative development. Herein, the collective pluripotency of an anarchic, cycling *piwi-1+* population generates the diversity of cell types required for the development of all temporary and definitive organ systems in these bilaterally symmetric, triploblastic animals. We showed that *piwi-1+* blastomeres are spatially disordered within the embryonic wall during S3--S4, and that dispersed epidermal, gut, muscle and neural progenitors arise within the blastomere population during S5. Further investigation is needed to understand how signals from differentiated tissues impact cell fate decisions within the *piwi-1+* blastomere compartment and effect progenitor cell migration, communication and interactions necessary to form organ rudiments.

*Smed* embryogenesis provides a unique vantage point from which to investigate the origin, anatomical composition and signaling logic underlying the neoblast niche. During sphere formation, differentiating blastomeres must interact and self-assemble temporary embryonic tissues, providing structure to the embryo and establishing a microenvironment that promotes maintenance and expansion of *piwi-1+* blastomeres. In turn, blastomeres are likely to effect changes that are conducive to the establishment and/or maintenance of the neoblast population. Neoblast lineages are predicted to actively maintain their niche during the lifetime of the animal. Although the adult gastrovascular system has long been suspected of providing trophic support signals to neoblasts ([@bib19]), the molecular mechanisms underlying this phenomenon remain elusive. Expansion of *piwi-1+* blastomeres correlates with that of an ill-defined embryonic gut population ([Figure 1---figure supplement 13A--D](#fig1s13){ref-type="fig"}). Investigating gut development and gut communication with the *piwi-1+* population during embryogenesis may uncover key regulators of neoblast specification or regulators of neoblast dynamics that may similarly impact stem cell behavior during adulthood.

We report that many transcripts implicated in lineage commitment and classification of neoblast subclasses wereexpressed at low levels in early embryos and were dramatically upregulated as organogenesis began. This observation is consistent with the hypothesis that neoblast heterogeneity is due to the presence of different subpopulations of cycling, lineage-primed progenitors within the compartment ([@bib59]). It also suggests that organ formation during embryogenesis probably utilizes many of the same genetic regulatory networks and transition states elucidated during adult homeostasis and regeneration. Development of techniques to interrogate gene function during embryogenesis will enable us to identify master regulators of organogenesis for different tissues, and to address similarities and differences in their modes of action during embryogenesis and adulthood. Embryogenesis may also provide a vantage point for the identification of upstream activators for these developmental TFs, helping to address how diverse, dispersed patterns of gene activation arise in the blastomere and neoblast compartments.

The key distinction between embryogenesis and regeneration is the de novo formation of tissues in the former, and the presence of preexisting structures and signaling environments in the latter. Studies can now be performed to assess how tissues that are hypothesized to be instructive for regeneration are initially established during embryogenesis, and how the formation of these tissues relates to the acquisition of regenerative potential during development. For example, planarian body wall muscle is hypothesized to be required for the re-specification of axial identities during regeneration ([@bib87]). At present, technical limitations preclude tissue-specific knockdown experiments that would address requirements for polarity genes in muscle during regeneration. However, we can now address when and how the definitive axes are established during *Smed* embryogenesis, including the identification of tissues and signals that initially polarize embryos prior to the development of body wall muscle. Examining axis formation during embryogenesis, and comparing the process across different chronological and developmental contexts, may uncover roles for additional tissues and/or novel polarity regulators. Furthermore, we can address which developmental milestones and gene products are required to establish a state of regeneration competency in the embryo.

Sustained effort and continued investment in the adaptation and development of new technologies for the molecular interrogation of *Smed* embryogenesis will facilitate discoveries that may challenge long-held assumptions about developmental processes, including cell fate specification, pattern formation and adult stem cell regulation. Moreover, utilizing *Smed* for comparative studies of embryogenesis and regeneration presents an unprecedented opportunity for formal examination of the embryonic origins of regenerative potential.

Materials and methods {#s4}
=====================

Planaria culture and husbandry {#s4-1}
------------------------------

Sexually reproducing *S. mediterranea* (*Smed*) stocks were descendants of animals collected in Sardinia by Dr. Maria Pala in 1999. Animals from the clonally derived sexual strain S2F1L3F2 ([@bib84]) and from the asexual clonal strain CIW-4 (C4) ([@bib49]) were propagated via successive rounds of amputation and regeneration. Animals were maintained in 1x Montjuic water at 20°C in the dark and fed homogenized beef liver as previously described in [@bib11]. Cultures subjected to intensive cutting and/or feeding regimens were supplemented with 100 µg/mL gentamicin sulfate (Gemini Bioproducts, \#400--100P).

Egg capsules were collected daily from outbred cohorts of sexually mature adults cultured at low density (6--8 animals per 400 mL culture), and were stored in dated Petri dishes at 20°C in constant darkness until use. The collection date was considered 1 day post-egg capsule deposition. To maintain optimal fertility levels, sexually mature animals used for egg capsule collections were replaced every 3--4 months with either juveniles (6--8 weeks post hatching) or adult regenerates (6--8 weeks post cut).

Single embryo RNA-Seq {#s4-2}
---------------------

Live embryos were dissected out of egg capsules in 1x Holfreter's buffer (3.5 g/L NaCl; 0.2 g/L NaHCO~3~; 0.05 g/L KCl; 0.2 g/L MgSO~4~; 0.1 g/L CaCl~2~; 1.0 g/L dextrose, pH 7.0--7.5) for S2--S7 egg capsules, or 1x Montjuic water for S8 hatchlings. Yolk (Y) samples were obtained from 8 d egg capsules that contained neither spherical nor elongating embryos. Single embryos were imaged on a Leica M205 FA dissecting microscope, transferred into microfuge tubes containing 200 µl TRIzol reagent (Thermo Fisher, item \#15596--018), homogenized by pipetting, and stored at −80°C. Single animal samples of intact C4 adults and virgin, sexually mature adults were homogenized in 1.0 mL TRIzol using an IKA Ultra Turrax T 25 Basic tissue disruptor prior to storage at −80°C. Total RNA extraction was performed in 1.0 mL TRIzol per sample according to the manufacturer's protocol, following the recommendations for working with small amounts of tissue. Pellets were resuspended in 25 µl nuclease free water, and 5 µl aliquots were reserved for quality control testing. Total RNA concentration and integrity were determined using Agilent Bioanalyzer 2100 Expert Total RNA Nano or Pico chips (Agilent Technologies, items \# 5067--1511 and 5067--1513). Total RNA samples were prepared for ten biological replicates per time point, and total RNA quality and yield were considered along with embryo size and morphology when selecting samples for library construction.

PolyA-selected, single-stranded RNA-Seq libraries were prepared for four biological replicates per stage using the Illumina TruSeq RNA Sample V2 kit (item \# RS-122--2001 and RS-122--2002), starting with 500 ng total RNA per sample (C4, virgin sexual adult \[SX\], Y, S4, S5, S6, S7, S8), or 100 ng total RNA per sample (S2, S3). Library concentrations and insert sizes were determined using Agilent Bioanalyzer DNA 1000 chips (Agilent Technologies, item \# 5067--1504), and diluted, pooled samples were reanalyzed with Agilent Bioanalyzer 2100 DNA High Sensitivity chips (Agilent Technologies, item \# 5067--4626). Nine barcoded samples, one replicate per time point (S2--S8, Y, C4) were pooled and sequenced per flow cell lane. Single end, 50 bp reads were acquired on an Illumina Hi-Seq 2000 sequencer. Illumina Primary Analysis version RTA 1.13.48.0 and Secondary Analysis version CASAVA-1.8.2 were run to demultiplex reads and generate FASTQ files. Barcoded SX replicates were pooled and run on a single flow cell lane of a HiSeq 2500, and Illumina Primary Analysis version RTA 1.17.21.3 and Secondary Analysis version CASAVA-1.8.2 were used. The RNA-Seq data have been deposited in the GEO database under the accession number GSE82280.

Mapping sequencing reads to the smed_20140614 transcriptome {#s4-3}
-----------------------------------------------------------

Sequencing reads were mapped to the smed_20140614 reference transcriptome (n = 36,035 transcripts) ([@bib76]), which contains sequencing data from de novo Trinity assemblies from the C4 and sexual biotypes, staged embryo collections, sorted cycling (X1) cells, and previously published sources ([@bib1]\], \[[@bib9]\]; the Dresden transcript collection at PlanMine \[<http://planmine.mpi-cbg.de>\]). Transcripts were consolidated and reduced to a unique set using the CD-HIT program ([@bib20]). smed_20140614 sequences may be downloaded from <http://smedgd.stowers.org.> Reads were mapped using the Bowtie algorithm, Version 1.0.0 ([@bib37]), allowing for two mismatches and up to five multi-matches (\--best \--strata -v 2 m 5). Read counts for transcripts were tabulated from SAM files using a custom script. Of 36,035 transcripts, 32,000 accumulated ≥1 CPM across all 40 samples. Samples were each sequenced to an average depth of 19 million reads, and exhibited an average map rate of 89% to the transcriptome.

RPKM normalization {#s4-4}
------------------

RPKM ([R]{.ul}eads [P]{.ul}er [K]{.ul}ilobase per [M]{.ul}illion) values were scaled using TMM normalization ([@bib62]) in edgeR to account for read depth across samples. In addition, 16s ribosomal RNA transcripts (SMED30032887), which soak up a significant but variable fraction of reads per sample, were removed prior to calculating RPKM values.

Identification of differentially expressed transcripts {#s4-5}
------------------------------------------------------

Differential gene expression was evaluated using the edgeR library ([@bib62]), and adjusted p-values were calculated as described in [@bib30]. Pairwise comparisons were performed between adjacent time points using edgeR: Y vs S2, S2 vs S3, S3 vs S4, S4 vs S5, S5 vs S6, S6 vs S7 and S7 vs S8. Mapped data were filtered to remove transcripts with less than a sum of 1 CPM across all 32 samples, resulting in 30,766 transcripts. The maximum read sum across samples for omitted transcripts was 14. In addition, transcripts for the 28S (SMED30027845), 18S (SMED30032663) and 16S (SMED30032887) ribosomal subunits were removed. Differentially expressed genes were identified in mixed stage reference comparisons using the GLM approach in edgeR to contrast each treatment group (i.e., developmental stage) to the average of the remaining groups (Y, S2--S8). Non-redundant lists of enriched transcripts from the pairwise and mixed stage reference comparisons, for S2 through S8, were subject to Euclidean distance clustering using scaled RPKM data in edgeR ([Figure 1C--I](#fig1){ref-type="fig"}, [Figure 1---figure supplements 4](#fig1s4){ref-type="fig"}--[10](#fig1s10){ref-type="fig"}, [Figure 1---source data 2](#SD2-data){ref-type="supplementary-material"}--[8](#SD8-data){ref-type="supplementary-material"}).

GO analysis {#s4-6}
-----------

Gene Ontology (GO) terms ([@bib23]) were assigned to smed_20140614 transcripts on the basis of homologous PFAM domains ([@bib18]) and significant Swiss-Prot hits (E-value ≤ 0.001), ([@bib77]). GO term enrichment queries were performed using the R software package topGO, version 2.20.0 ([@bib2]). GO analysis was performed on the non-redundant lists of enriched transcripts for S2--S8 ([Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). Categories containing similar and/or related Biological Process (BP) GO ids enriched at one or more time point(s) were generated manually ([Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). Enriched BP GO ids selected for categorization had Benjamini-Hochberg corrected p-values ≤1e-10 ([@bib8]), and must have been associated with ≥1% of the enriched transcripts for the developmental stage(s) in question. BP GO ids were only assigned to one category. BP GO ids that did not describe a cell and/or tissue type present in *Smed* (e.g., heart, lung, neural crest) were omitted. Using these categories as a guide, lists of enriched BP GO ids and non-redundant lists of associated transcripts were generated for S2--S8 ([Figure 1---source data 2](#SD2-data){ref-type="supplementary-material"}--[8](#SD8-data){ref-type="supplementary-material"}). Transcripts may appear in more than one BP GO id category, just as transcripts may be associated with more than one GO term.

Neoblast enriched transcript analysis {#s4-7}
-------------------------------------

The neoblast enriched transcript list (n = 242) emerged from the downregulated sequences in whole animals at 24 and/or 48 hr post-lethal irradiation in three independent experiments ([@bib15]; [@bib83]) (Chen and Sánchez Alvarado, personal communication) ([Figure 4A](#fig4){ref-type="fig"}, [Figure 4---source data 1](#SD10-data){ref-type="supplementary-material"}). Euclidean distance clustering was performed using the mixed stage reference comparison data.

Cloning {#s4-8}
-------

Constructs for riboprobe synthesis were constructed using the pPR-T4P (J. Rink) cloning strategy described in [@bib1], with the exception that PCR inserts were amplified using mixed stage embryo cDNA (S2--S8) as a template. Primers used for cloning EEE transcripts and insert sequences appear in [Figure 5---source data 3](#SD13-data){ref-type="supplementary-material"}.

Whole mount in situ hybridization (WISH) and immunostaining {#s4-9}
-----------------------------------------------------------

Colorimetric and fluorescent WISH was performed as described by [@bib34]) and [@bib53]), with the following modifications:

1.  1\) Egg capsules for S2--S7 embryos (2--10 days post-egg capsule deposition) were punctured with an insect pin and fixed in 4% formaldehyde in 1x PBS-Triton X (PBSTx) 0.5% for 4--6 hr at room temperature. Fixed embryos were dissected out from the egg capsules, washed in 1x PBSTx (0.5%) for 10 min, and subjected to incremental dehydration in methanol (10 min in 50% methanol, 2 × 10 min in 100% methanol). Fixed embryos were stored at −20°C. S2--S7 embryos were not bleached. Proteinase K treatment was increased to 20 min.

2.  S8 embryos (newborn hatchlings, 14--16 days post-egg capsule deposition) were removed from egg capsules prior to fixation. S8 embryos and C4 intact adults (2--4 mm) were incubated in 4% formaldehyde in PBSTx (0.5%) for one hour at room temperature.

3.  3\) S2--S7 embryos were not bleached. S8 embryos and C4 adults were bleached in formamide bleaching solution for 30 min to 1 hr under bright light.

4.  Transplanted S2F1L3F2 hosts and irradiated intact controls (\~5--6 mm in length) were fixed for 90 min. Worms were bleached for 1.5--2 hr in formamide bleaching solution under bright light.

Immunostaining was performed after fluorescent WISH development with rabbit polyclonal antibodies against H3S10p (1:1000; Millipore \# 06--570), mouse monoclonal antibodies against Smith Antigen (Y12) (1:200, ThermoFisher Scientific, PIMA190490), or mouse monoclonal antibodies against *Smed* PIWI-1 (1:1000, a generous gift from J. Rink). H3S10p antibodies were detected using preabsorbed Alexa-conjugated secondary antibodies (1:1000, Abcam, ab150086, ab150069, ab150071), while anti-Y12 and anti-PIWI staining was visualized with tyramide development using Goat anti-mouse IgG F(ab\')2 HRP (1:1000, Jackson Immunoresearch \#115-036-072). Nuclear staining was performed with DAPI (1:5000, 1 mg/mL stock solution, ThermoFisher Scientific, D1306) or with Sytox Green (1:5000, 5 mM stock solution, ThermoFisher Scientific, S7020).

S2---S8 colorimetric and fluorescent WISH samples that were to be imaged using light sheet microscopy were mounted as described in the Microscopy section, whereas others were mounted in 80% glycerol supplemented with 2.5% DABCO. C4 and sexual adult samples were mounted in Scale A2 mounting media ([@bib28]).

Histology {#s4-10}
---------

Embryos (S2--S8) were fixed for 4 hr at room temperature in 4% formaldehyde in 1x PBS, followed by 3 × 10 min washes in 1x PBS and gradual dehydration in 30%, 50%, 70%, 80%, 95% and 100% ethanol. The samples were soaked for 30 min in 5% glycerol diluted in 100% ethanol, cleared in xylene for 10 min, then soaked in two changes of Clear-rite 3 (Richard-Allan Scientific) for a total of 25 min. Paraffin infiltration proceeded with 2 × 45 min incubations, and embedded embryos underwent serial sectioning (5 µm thickness). Paraffin was removed prior to staining by heating slides at 60°C for 20 min, then performing 3 × 2 min washes in xylene, 3 × 1 min washes in 100% ethanol, 3 × 1 min washes in 80% ethanol before rinsing in tap water. Hematoxylin and eosin staining was performed using the ST Infinity H and E Staining System (Leica Biosystems) in a Leica Autostainer. Slides were incubated for 30 s in Hemalast, then for 2 min in hematoxylin, and were rinsed for 2 min in tap water. Next, slides were incubated for 45 s in differentiator and for 1 min in bluing agent, with each step followed by a 1 min tap water rinse and a 1 min incubation in 80% ethanol. Slides were stained with eosin for 30 s, dehydrated 3 × 1 min in 100% ethanol and cleared in 3 × 1 min incubations in xylene.

Microscopy {#s4-11}
----------

A Leica M205 FA stereomicroscope was used to capture images of live animals and colorimetric WISH samples. A Leica DM600B upright microscope was used to capture images of histological sections. A Zeiss LSM-510-VIS confocal and a customized light sheet microscope were used to capture Z-stacks for fluorescent WISH samples.

Fixed, stained *Smed* embryos were mounted in 1% low melt agarose in 1x PBS along with fluorescent conjugated beads required for image registration and reconstruction (FluoSpheres Polystyrene Microspheres, 1.0 µm, red fluorescent \[580/605\], Invitrogen/Molecular Probes, F13083; FluoSpheres Carboxylate Modified Microspheres, 0.1 µm, yellow-green fluorescent \[505/515\], Invitrogen/Molecular Probes, F8803). 1 µM fluorescent bead stock solutions were diluted 1:10,000--1: 360,000, depending on the size of the embryo and the magnification of the detection objective used. Samples were placed in an imaging chamber within a Single Plane Illumination Microscopy (SPIM) system described in [@bib47]. S3--S5 embryos were imaged using either a 10x Plan Apochromat or a 5x Plan NeoFluar objective. Z-stacks were taken every 45˚ around the surface of the samples using a rotating stage, producing eight stacks of images per embryo. Multiview data sets were reconstructed using Fiji SPIM plugins for data registration and fusion ([@bib56]). Reconstructed data sets were viewed in the Imaris software package, where they were cropped and masked to remove beads. Cell positions and the embryonic pharynx were marked manually using the 3D Spot Finder function, and the three-dimensional coordinates for marked cells were exported into excel for analysis of cell positions. Colocalization was determined manually on S3--S4 whole embryos, or on crop3D sections (100 µm X 200 µm X 100 µm) of S5 embryos.

Cell position analysis on reconstructed SPIM images {#s4-12}
---------------------------------------------------

Three-dimensional coordinates for *piwi-1+* cells or mitotic cells (*piwi-1+,* H3S10p+), the embryonic pharynx, and the embryo center were exported from SPIM reconstructions of S3 and S4 embryos. Spot positions collected in IMARIS were shifted and rotated in MATLAB to a coordinate system where the embryonic center was at the origin and the embryonic pharynx on the z-axis. Relative theta distribution likelihoods of the form (1-exp(-θ/θ'))\*sin(θ) were calculated by assuming a θ' and calculating the likelihood that such a distribution would produce the observed data by multiplying together the individual probabilities. The uncertainty in the best fit θ'' was found by simulating several datasets, each with a number of cells equal to those observed in the actual data and having a dampening term of θ''. For each dataset, the most likely θ' was found, the standard deviation of which was taken to be the error in θ''.

Nanostring nCounter digital expression analysis {#s4-13}
-----------------------------------------------

Total RNA samples from single embryos and adults (S2--S8, Y, C4 and SX; four biological replicates per sample) were prepared as described for single-animal RNA-Seq. 100 ng total RNA per sample was assayed on the Nanostring nCounter platform ([@bib22]) using a custom-made probe set. Reporter and capture probe sequences can be found in [Figure 5---source data 2](#SD12-data){ref-type="supplementary-material"}. Housekeeping control genes were reported in [@bib86]. Nanostring data was normalized using the NanoStringNorm library from Bioconductor ([@bib82]), using the sum of the positive controls and the sum of the housekeeping genes as independent normalization factors, with the mean of the negative controls used to estimate background. Raw and normalized nanostring data can be found in [Figure 5---source data 2](#SD12-data){ref-type="supplementary-material"}.

Bulk cell transplantation {#s4-14}
-------------------------

Host animals (5--7 mm in length, ≥7 day starved) were selected from the clonally derived *Smed* sexual strain S2F1L3F2 ([@bib84]) and were cultured in 1x Montjuic water supplemented with 100 µg/mL gentamicin sulfate. The host neoblast population was ablated by exposure to 6,000 Rads on a GammaCell 40 Exactor irradiator; cohorts of unirradiated animals were reserved to verify complete elimination of the neoblast population by WISH with riboprobes against *piwi-1.*

Whole-embryo cell suspensions were created for S4, S5, S6, S7 or S8 by mechanically disrupting embryos in chilled, freshly made 1x Holfreter's solution +5% heat-inactivated fetal bovine serum (Sigma Aldrich, F4135) via repeated pipetting. Ten embryos were disrupted per cell suspension for S5, S6, S7 and S8, whereas 20--35 embryos were disrupted per S4 cell suspension. S4, S5 and S6 embryos were typically 'eviscerated' prior to pipetting by poking with an insect pin and gently squeezing out ingested yolk from the gut. Cell suspension volumes were adjusted to 1.0 mL before samples were filtered through 20 µm (all stages) and 10 µm (S5--S8) cell strainers (Partec CellTrics, Sysmex, 04-0042-2315 \[20 µm\], 04-0042-2314 \[10 µm\]) into low-retention microfuge tubes. Cells were pelleted by centrifugation at 310 rcf for 5 min, were resuspended in a final volume of \~10 µL (S5--S8) or \~5 µl (S4), and were kept on ice during transplantation.

Embryo cell suspensions were loaded by mouth pipetting into borosilicate glass needles (Sutter Instrument Co., \#B100-75-15) pulled using a flaming/brown micropipette puller (Sutter Instrument Co., Model P-97) and were injected using an Eppendorf FemtoJet at 1.0--1.5 psi, as described by [@bib84]). Hosts were immobilized on a cold peltier plate, ventral side up, and cells were injected into the tail stripe (i.e., the medial, post-pharyngeal parenchymal space between the two posterior branches of the intestine). Hosts were injected at 1 day post-irradiation (dpi) for rescue experiments and at 3 dpi for short-term experiments. Transplanted animals and uninjected, 6,000-Rad-irradiated hosts for rescue experiments were maintained individually in 3 cm petri dishes at 20°C in the dark, with water exchanges and visual inspection of animals performed every 2--3 days. Transplanted animals slated for fixation were reared in 10 cm petri dishes, with 10 or fewer animals per dish, with water exchanges every 2--3 days.

Online data repository {#s4-15}
----------------------

Original data underlying this manuscript can be accessed from the Stowers Original Data Repository at <http://www.stowers.org/research/publications/libpb-1086>
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Summary:

In this manuscript, Davies and colleagues investigate the developmental origins of adult pluripotent stem cells (neoblasts) in the planarian *Schmidtea mediterranea*. The authors provide a comprehensive characterization of *S. mediterranea* embryogenesis by meticulously cataloguing (with corresponding gene expression data and expression mapping) the different stages of embryonic development. This groundwork allowed the authors to ask when neoblasts originate during embryogenesis. The authors demonstrate that neoblasts arise from anarchic, cycling *piwi*-1+ cells, which generate all temporary and definitive tissues/organs during embryonic development. Interestingly, early embryonic *piwi*-1+ cells have a distinct molecular signature from neoblasts. Unlike neoblasts, which express transcription factors (TFs) important for development, early embryonic *piwi*-1+ cells express \"early embryo enriched\" (EEE) transcripts. Later in embryogenesis when organogenesis initiates, EEE transcripts are downregulated while various developmental TFs are upregulated. Strikingly, in an elegant set of transplantation experiments, the authors demonstrate that *piwi*-1+ cells are functionally different at different embryonic stages. Similar to transplanted adult neoblasts, transplanted *piwi*-1+ cells from embryos undergoing organogenesis can rescue lethally irradiated planarians that are devoid of neoblasts, whereas, early EEEhi/TFlo *piwi*-1+ cells cannot.

Essential revisions:

Usually for minor revisions, we make a summary of the reviewers\' comments, but in this case, the majority of questions raised are regarding lack of clarity in the manuscript and the complexity of data presentation. So we are including the detailed comments below. All of these can be addressed by rewriting the manuscript making it more accessible to readers. Also, below I paste an exchange between the reviewers during the post review session:

\" I did want to address one point raised by two other reviewers, which I think reflects the way in which the data presentation could be improved. Both raised concerns about the transplant experiments that were easy to miss because some of the key results were buried in the supplement.

The \"no transplant\" control is shown in [Figure 7F](#fig7){ref-type="fig"}. As expected (and shown previously) no planarians survive irradiation. Figure 7---figure supplement 2 shows *piwi*-1+ cell counts. In panel B the authors show the percentage of transplants with *piwi*-1+ cells at 1 hpt (directly after transplantation), which indicates that \"the cell injection technique was robust and reliable\". Panel C shows the number of *piwi*-1+ cells per transplant at 1 hpt. For example, in Figure 7---figure supplement 2, one can see that comparable numbers of *piwi*-1+ cells were transplanted from S5 and S6 embryos (1 hpt) but at 5 dpt, very few to zero *piwi*-1+ cells remain from S5 donors compared to S6 (panel E). Furthermore, irradiated hosts transplanted with S5 *piwi*-1+ donor cells are not rescued ([Figure 7F](#fig7){ref-type="fig"}). The authors mention these data in the text (subsection "Embryos undergoing organogenesis contain cells with cNeoblast activity"), but it might be helpful to the reader if these data were in the main figure and not buried in the supplement. Furthermore, some of the panels can be merged (for example the 1 hpt and 5 dpt *piwi*-1+ cell transplants) so that it is easier for the reader to compare the data. \"

As you can see, the reviewers, as much as they admired the science, were confused by the presentation. So, please make the paper a bit more lucid for the readership of *eLife*.

Reviewer \#1

This impressive body of work will be a valuable resource to planarian biologists. To make the manuscript accessible to a broader audience and more manageable for readers in general, here are some editing suggestions that should be addressed before publication:

1\) To appeal to the broader *eLife* audience, the authors should provide more description/context in the main text to help non-experts understand the results presented. This includes data the authors deem not essential for the narrative of the paper and is found in Supplementary Online Material instead of the main text. For example, sphere formation (subsection "Anarchic, cycling *piwi*-1+ blastomeres fuel Smed embryonic development") is not defined in the main text, but is described in the SOM as beginning during Stage 2. Furthermore, the distinction between temporary and definitive embryonic organs may not be entirely clear to non-expert readers. The authors do a better job describing this uncommon developmental phenomenon in the SOM (e.g., \"The embryonic pharynx degenerates during S6, as the definitive pharynx primordium develops beneath it. Embryonic pharynx markers are no longer detectable by S7\").

2\) Throughout the manuscript, the authors are urged to present figures in the order they are referred to in the text. Looking up figures (and multiple Supplements) that are \"out of order\" is cumbersome, especially when considering the sheer volume of data the reader must go through. For example, [Figure 1---figure supplement 12](#fig1s12){ref-type="fig"} is referred to twice in the text (Results section) before any of the other [Figure 1](#fig1){ref-type="fig"} supplements. [Figure 1---figure supplement 12](#fig1s12){ref-type="fig"} should be designated as [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} (and all other [Figure 1](#fig1){ref-type="fig"} supplements renumbered accordingly thereafter). Also, having two sets of differently named supplemental data (Figure X---figure supplement Y, which is per the journal\'s style, and Supplementary Online Figure Z, which appears not to be) makes navigating supplementary material unnecessarily difficult for the reader.

3\) Introduction section: Remove the extensive discussion of results from the Introduction. This will also help shorten the overall length of the paper.

Reviewer \#2

Davies et all provide the first comprehensive description of *Smed* embryos at a molecular and anatomic level. This is not trivial given that *S. med* broods its embryos and the authors should be congratulated for this Herculean task. They specifically ask whether neoblasts that have been well studied in the adult planarian exist during embryogenesis and conclude that a cycling *piwi1*+ precursor population gives rise to organs as well as neoblasts, but is distinct on a molecular level as well as functionally in transplantation assays. Although important for the field, the following issues should be addressed:

Comments:

1\) Overall, the accessibility and readability for a generalist journal as this one should be increased. This can be accomplished by presuming less prior knowledge about planaria in the Results section and structuring the writing with summary statements at the end of each section in the Results. It might suggest that authors provide a succinct table with morphological criteria for embryo staging as well as key genes expression changes, accompanied with cartoons.

2\) Would it be possible to resolve S2 and S3 by growing the animals at a lower temperature?

3\) ISH studies need sense controls. Specifically, in later stages (S6-8), it is unclear whether some of the signal for *piwi1* in [Figure 1](#fig1){ref-type="fig"} could result from probe trapping or non-specific staining in the testes and ovary ducts.

4\) Subsection "Progenitors for definitive lineages arise within *piwi*-1+ blastomeres as organogenesis commences" refers to data presumably not shown demonstrating that \~4% of cells expressing PIWI1 by immunostaining at S5 do not harbor *piwi1* transcript, and suggest that the protein perdures after transcript degradation upon differentiation. Can the authors please clarify whether all *piwi*-1+ cells expressed PIWI1 protein in the embryos?

5\) My main concern with the authors conclusions lies in the transplant studies. Can the authors please estimate how many cells were transplanted, or how many embryo equivalents. [Figure 7B](#fig7){ref-type="fig"} should show a no transplant control (which presumably will not contribute) as well as cNeoblast control from adult (which will presumably contribute more robustly than the embryos). The authors need to demonstrate that *piwi*+ cells and structures rescued following irradiation are donor-derived, as this will dismiss the possibility that the blastomere graft rejuvenates host cells; this can be accomplished genetically by the phenotype of regenerated structures as well as by using a marker such as PKH26 of the donor cells.

Reviewer \#3

Davies et al. present a molecular, cellular, and morphological study of planarian (*S. mediterranea*) embryogenesis. They report a molecular resource of stage-enriched genes useful for staging embryos and for studying gene function in embryogenesis, including the discovery of embryo-enriched planarian gene expression. They show that *piwi*+ cells are present throughout embryogenesis, but that lineages for adult tissues only develop within this *piwi*+ population at a particular stage (S5). Interestingly, in transplant experiments, clonogenic (colony-forming) neoblast activity also develops at a particular stage, approximately when lineages appear. The manuscript is an impressive body of work and well written. This paper will be an important landmark in the study of embryogenesis and its comparison to regeneration in planarians.

Abstract:

\"Neoblast subpopulations established during embryogenesis persist into adulthood\"

Subpopulations may not persist as subpopulations, rather continuously generated. Since the renewal capacity of subpopulations is unknown, different wording is suggested.

Results section:

\"seven morphologically distinct stages (S), S2-S8\" were selected for sequencing. Panels D-F contain embryos that look superficially similar; thus it would be helpful for the authors to further describe at this point in the text the criteria for stage separation in the sequencing experiment (I assume time of development was also a factor?).

\"pairwise comparisons of adjacent time points\"

These aren\'t really \"time points\", since stages overlap in timing. Different wording is suggested.

Assessment of most statements of data in the text is difficult, because each one requires a goose chase through excel tables, main figures, figure supplements, and online-only figures. Some items called out as figure supplements are not figures but tables with titles different than their figure supplement title. Take subsection "Anarchic, cycling *piwi*-1+ blastomeres fuel Smed embryonic development", for example; this single sentence refers to 4 panels in 2 main figures, 4 Figure supplements, and 3 supplementary online figures. I tried to find [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} to look at the markers for all known and restricted embryonic cell populations and eventually gave up...

Paragraph four in subsection "Anarchic, cycling *piwi*-1+ blastomeres fuel Smed embryonic development". The paragraph could use a concluding sentence to clarify message.

Similarly, the point of \"...sample sizes, the optimal θ\' was calculated to be 0.58 +/- 0.33,and was 50-fold more likely to explain the observed trend than a simple normal distribution.\" is not clear.

Last paragraph of the subsection: restriction of cell cycle activity to *piwi*+ cells in adults should reference the *piwi*-1 2005 paper and could also reference Wagner 2011, which had further analysis of this marker for all dividing cells.

Figure 4---figure supplement 2 Y12 data is interesting, but only S4 staining is apparent. If it is not present in *piwi*+ cells at earlier stages this merits display. The chromatoid body presence could also be considered for a main figure.

Subsection "Early embryo enriched transcripts expressed throughout *piwi*-1+ blastomeres are downregulated as organogenesis begins". Naming clusters \"6\" \"5\" can be deciphered from examination from the figure, but is not immediately clear what these are when reading the text. i.e., individual of the multiple clusters of S2-S4-enriched txts that showed downregulation at S5 and thereafter.

The third paragraph in this section presents analysis of expression of the interesting EEE genes. However, the main messages/synthesis is hard to decipher because of the distracting links out to disparate files/figure locations. The narrative/text feels beholden to a set of files and figures as opposed to the other way around.

More discussion of the EEE genes that are expressed broadly in the embryo would be of interest. What types of genes were discovered?

Reviewer \#4

This manuscript contains a large amount of information, much of it contained in supplementary materials. It is an important piece of work, because ([@bib1]) it addresses the expression of genes on a genome wide scale during the development of a planarian flatworm; ([@bib3]) it addresses the origin and development of neoblasts.

That being said, in its current form, the manuscript is very difficult to digest. The writing is long (section 5 of the Results alone has 6.5 pages!) and \"windy: (see example given for section 2 below), and there are some fundamental questions that are either not addressed, or the answers are \"hidden\" in the long narrative.

Specific comments:

The Introduction is long and detailed on many aspects of neoblast biology, but at the same time unclear and lacking in other aspects. Generally, I am often not sure whether the authors talk about facts known from previous studies, or are already highlighting the findings to be reported in this paper.

Suggestion: shorten the intro by at least 50%. After (in a briefer format than now) summarizing known functions and types of neoblasts in adults/regeneration, summarize literature (as far as it exists) regarding

-embryogenesis in planarians (see below; the statements about embryogenesis that are now found in section 2 of the Results should be in the Introduction)

-specifically, what is said in the literature where/when do neoblasts first appear in embryos (there will probably not be a lot of published information; one example is Ramachandra et al., 1999, on embryonic BrdU -positive presumed neoblasts in an Acoel).

-proliferation, migration, differentiation of neoblasts during embryonic period.

Results

Section 1: surveys molecular staging; stages themselves described in supplementary table and figures. This is a useful and important work of reference for the planarian developmental field.

Please highlight in the text:

-what in terms of morphogenesis and organogenesis is novel compared to the previous embryological study of *Schmidtea polychroa* (Cardona et al)

-how do stages utilized here (1-8) differ from the 8 previously introduced ones

-what does molecular profiling add to defining stages (clearer temporal distinction?..)

Section 2 -- "Anarchic, cycling *piwi*-1+ blastomeres fuel Smed embryonic development"

The section describes the expression pattern of *piwi*, and concludes that the gene is restricted to undifferentiated cells. The text is very difficult to read. Different types of information are intermingled. For example, paragraph two summarizes a result known from the literature. Talks about general expression patterns of non-specified transcripts, documented only in the supplementary material, in differentiating cells. later in the paragraph you speak to the point: *piwi* is expressed in undifferentiated cells in the bodywall at the S3 stage. But how does the pan-nuclear marker EF1a-like 1 show that, since this marker appears to be expressed in all cells (including the *piwi*-positive ones)? The final sentences again talk about findings from the previous literature.

I suggest to remove all references to the previous literature from this (Results) section; put them in the Introduction, and in the Results focus on where exactly *piwi* is expressed. Specifically:

Paragraphs 1-2

-DAPI shows large number of labeled dots: are these all nuclei of blastomeres ([Figure 2A, C](#fig2){ref-type="fig"})?

-if so, only a small subset of blastomeres expresses *piwi* (2A): how would one characterize distribution? Clustered, around embryonic pharynx?

-Paragraph 2: sounds like *piwi* is downregulated in many cells. What is shown ([Figure 2A](#fig2){ref-type="fig"}) is that from beginning, *piwi* is expressed in only few blastomeres (if DAPI really reflects all nuclei). Is there an earlier stage with many more *piwi*+ cells?

-the pattern and dynamics of *piwi* in undifferentiated cells (\"blastomeres\") remains a bit vague. Is the pattern the following: stage 1, before embryonic transient cells differentiate: all cells express *piwi*stage 2/3: as embryonic cells differentiate, they lose *piwi*; ALL other cells retain it later stages: as adult cells become postmitotic, they lose *piwi*; ALL other cells retain it

I don\'t think this is what happens. But the authors do not make it clear in text and figures what exactly happens. I assume that only a small subset of undifferentiated cells express *piwi*. I understand that these are distributed. This information needs to be settled; it is one of the crucial pieces of data required in subsequent sections (see comments below).

Section 3 reports that genes sets known to be associated with adult neoblasts are also expressed in the embryo. This is an important finding. The main question is:

-are these genes, in the embryo (e.g., S4, S5, S6), restricted to *piwi*+ cells?

-are they restricted to ALL undifferentiated cells (assuming that not all undifferentiated cells are *piwi*+; see my questions/comments above)

-are they also expressed in cells that stop dividing and differentiate?

I was not able to find a clear answer to these questions in the text.

Section 4 Early embryonic genes (EEE)

I don\'t understand the message of this section. One reason for confusion arises right at the beginning:

\- in the opening lines the authors talk about \"S2-S4 enriched transcripts expressed throughout the *piwi* blastomere population\".

\- then the authors introduce the 1048 EEE genes: are these the same as above (i.e., they are expressed in the *piwi* blastomere population)?

\- because, if they are: why do *piwi* (undifferentiated) blastomeres and differentiated (transient embryonic cells) express the same set of genes? I thought from the previous sections (and on general grounds) that as cells become postmitotic and differentiate, they switch on different genetic programs.

Section 5

It is shown that gene sets associated with specific differentiated cell types are upregulated around stage 5, which is important, but expected, since it confirms the observation that cells differentiate (structurally) at this stage.

The main claim of the heading of this section (that progenitors of specific cell types arise WIHIN the *piwi*-positive population) needs to be demonstrated, and/or described more clearly (see questions to section 2 above)

Section 6

Cell suspensions derived from embryos at different stages (S5-S8) were injected into irradiated adults, and were able to rescue them. This is also an important experiment. A puzzling finding was that cells from S5 embryos were unable to rescue. Is it possible that S5 embryos did not have a high enough density of *piwi*+ cells to do the job? Is it possible to get a value for the number of *piwi*+ cells present in an aliquot of the cell suspension from different stage embryos?

10.7554/eLife.21052.064

Author response

Reviewer \#1

This impressive body of work will be a valuable resource to planarian biologists. To make the manuscript accessible to a broader audience and more manageable for readers in general, here are some editing suggestions that should be addressed before publication:

1\) To appeal to the broader eLife audience, the authors should provide more description/context in the main text to help non-experts understand the results presented. This includes data the authors deem not essential for the narrative of the paper and is found in Supplementary Online Material instead of the main text. For example, sphere formation (subsection "Anarchic, cycling piwi-1+ blastomeres fuel Smed embryonic development") is not defined in the main text, but is described in the SOM as beginning during Stage 2. Furthermore, the distinction between temporary and definitive embryonic organs may not be entirely clear to non-expert readers. The authors do a better job describing this uncommon developmental phenomenon in the SOM (e.g., \"The embryonic pharynx degenerates during S6, as the definitive pharynx primordium develops beneath it. Embryonic pharynx markers are no longer detectable by S7\").

The manuscript was revised extensively, with the goal of making our story accessible to a broad readership. Care has been taken to eliminate unnecessary specialist vocabulary and to clearly define terms as they are introduced. We shortened the Introduction, eliminating the extensive summary of our results. In addition, we emphasized the foundational resources, key results and conceptual breakthroughs stemming from our work. We added two new paragraphs to the start of the Results section, intended to give readers a crash course in freshwater flatworm embryology. We define necessary terminology and introduce key concepts, like direct development, ectolecithal embryos, dispersed cleavage, temporary embryonic tissues and definitive tissues. We reorganized [Figures 2](#fig2){ref-type="fig"} and [7](#fig7){ref-type="fig"} (now [Figures 2](#fig2){ref-type="fig"} and [7](#fig7){ref-type="fig"}--[9](#fig9){ref-type="fig"}, respectively) and rewrote the associated text and Figure Legends; we also rewrote much of the text accompanying [Figure 5](#fig5){ref-type="fig"}. To aid readers, we reorganized all of the supplemental data so that items are noted chronologically in the text. Supplementary files were broken down into supplemental figures, source data and rich media files. We hope this encourages readers to delve into the wealth of data provided with our manuscript. In addition, we generated an online searchable resource (<https://planosphere.stowers.org>) that houses the Molecular Staging Series and Molecular Fate Mapping Atlas. This resource, hosted by the Stowers Institute, will be freely available upon publication and will reference our published manuscript.

2\) Throughout the manuscript, the authors are urged to present figures in the order they are referred to in the text. Looking up figures (and multiple Supplements) that are \"out of order\" is cumbersome, especially when considering the sheer volume of data the reader must go through. For example, [Figure 1---figure supplement 12](#fig1s12){ref-type="fig"} is referred to twice in the text (Results section) before any of the other [Figure 1](#fig1){ref-type="fig"} supplements. [Figure 1---figure supplement 12](#fig1s12){ref-type="fig"} should be designated as [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} (and all other [Figure 1](#fig1){ref-type="fig"} supplements renumbered accordingly thereafter). Also, having two sets of differently named supplemental data (Figure X ---figure supplement Y, which is per the journal\'s style, and Supplementary Online Figure Z, which appears not to be) makes navigating supplementary material unnecessarily difficult for the reader.

To make it easier for readers to navigate through the extensive amount of supplemental data associated with our manuscript, we reorganized and renamed the supplemental data files as suggested by reviewer \#1. Figure supplement, source data and rich media files were renamed to reflect the order they are referred to in the text. Large excel tables are now listed as "source data" files; SPIM movies are listed as "rich media" files. In addition, the Molecular Fate Mapping Atlas, formerly the Supplementary Online Material and Supplementary Online [Figures 1](#fig1){ref-type="fig"}--[9](#fig9){ref-type="fig"}, are now labeled as [Figure 1---source data 9](#SD9-data){ref-type="supplementary-material"} and [Figure 1---figure supplements 11](#fig1s11){ref-type="fig"}--[19](#fig1s19){ref-type="fig"}. This was done to consolidate the supplementary data, and to eliminate the confusion created by having "figure supplements" and "Supplementary Online Material."

3\) Introduction section: Remove the extensive discussion of results from the Introduction. This will also help shorten the overall length of the paper.

The Introduction was shortened and reorganized, in accordance with suggestions from reviewers \#1 and \#4. The lines, which contained a detailed summary of our results, were removed from the Introduction.

Reviewer \#2

\[...\]Comments:

1\) Overall, the accessibility and readability for a generalist journal as this one should be increased. This can be accomplished by presuming less prior knowledge about planaria in the Results section and structuring the writing with summary statements at the end of each section in the Results. It might suggest that authors provide a succinct table with morphological criteria for embryo staging as well as key genes expression changes, accompanied with cartoons.

We revised the manuscript to make it more accessible to a general audience, and detailed the changes made in this regard in our response to reviewer \#1. To facilitate use of this staging system by others, <http://planosphere.stowers.org> provides cartoons, time (days post-egg capsule deposition), gene expression data (RNA-Seq and WISH), and written descriptions of embryo morphology for each of the stages queried.

2\) Would it be possible to resolve S2 and S3 by growing the animals at a lower temperature?

Early S2 embryos undergoing sphere formation are quite fragile and are difficult to detect in live, unstained samples; it's doubtful that simply lowering the temperature would make these samples easier to find. We are interested in performing gene expression profiling on oocytes, zygotes and early S2 embryos in the future. Laser capture microdissection, performed on fixed tissue stained with a nuclear dye, may be the best route to obtaining tissue for S2 and earlier stages. It is possible that injection of vital dye into oocytes, and/or EdU incorporation into oocytes or early blastomeres, would enable us to identify tissue for RNA-Seq in live samples, and to do lineage tracing studies. We are interested in identifying maternal RNAs contributed to oocytes, the onset of zygotic transcription -- which is likely quite early (*i.e.,* before we started our RNA-Seq time course), and determining when the first asymmetries in gene expression occur among the blastomeres. These experiments and are future directions for us.

3\) ISH studies need sense controls. Specifically, in later stages (S6-8), it is unclear whether some of the signal for piwi1 in [Figure 1](#fig1){ref-type="fig"} could result from probe trapping or non-specific staining in the testes and ovary ducts.

Hematoxylin and eosin staining is shown in [Figure 1](#fig1){ref-type="fig"}, not in situ hybridization data. *piwi-1* expression, shown first in [Figure 2](#fig2){ref-type="fig"}, always shows specific expression in parenchymal cells. It is unlikely that the *piwi-1+* signal is nonspecifically trapped in the reproductive system during S6-S8, since the testes, ovaries and somatic gonadal tissue are absent from S8 newborn hatchlings and arise weeks later during juvenile development. Incidentally, we detect *nanos* expression by WISH during S6-S8, in increasing numbers of cells with a noted dorsolateral bias and in the developing eyes (S7-S8). Our suspicion is that the dorsolaterally positioned cells are likely *piwi-1+, nanos+* primordial germ cells; we have not followed up on this point yet, and would need to costain with additional PGC markers as well. Consistent with our WISH results, *nanos* expression was undetectable by RNA-Seq until S5, and was lowly expressed in S5-S8 embryos.

4\) Subsection "Progenitors for definitive lineages arise within piwi-1+ blastomeres as organogenesis commences" refers to data presumably not shown demonstrating that \~4% of cells expressing PIWI1 by immunostaining at S5 do not harbor piwi1 transcript, and suggest that the protein perdures after transcript degradation upon differentiation. Can the authors please clarify whether all piwi-1+ cells expressed PIWI1 protein in the embryos?

Yes, *piwi-1+* cells also express PIWI-1 protein (99 +/- 0.4% *piwi-1+* cells were double positive for PIWI-1 protein, n= 4,152 *piwi-1+* cells scored, n= 4 S5 embryos). We amended the text to report this result and created a new figure, [Figure 6 ---figure supplement 1](#fig6s1){ref-type="fig"}, containing representative images. The quantification you requested is present in the [Figure 6 ---figure supplement 1](#fig6s1){ref-type="fig"} legend. The revised main manuscript text is included in our comments to reviewer \#1.

5\) My main concern with the authors conclusions lies in the transplant studies. Can the authors please estimate how many cells were transplanted, or how many embryo equivalents. [Figure 7B](#fig7){ref-type="fig"} should show a no transplant control (which presumably will not contribute) as well as cNeoblast control from adult (which will presumably contribute more robustly than the embryos). The authors need to demonstrate that piwi+ cells and structures rescued following irradiation are donor-derived, as this will dismiss the possibility that the blastomere graft rejuvenates host cells; this can be accomplished genetically by the phenotype of regenerated structures as well as by using a marker such as PKH26 of the donor cells.

We reorganized the presentation of the cell transplantation data and revised the associated text extensively to bring out some of the key points formerly house in the supplemental material. The transplantation experiments are now shown in [Figures 7](#fig7){ref-type="fig"} and 8. In [Figure 7C](#fig7){ref-type="fig"}, we show quantification for the number of *piwi-1+* cells per host at 1 hour and 5 days post-transplant. We show that comparable numbers of S5, S6, S7 and S8 cells are injected per host; an average injection generally delivers between 50-100 embryonic *piwi-1+* cells into the tail. We detail how the embryonic cell suspensions were prepared in the Materials and methods. We are able to get far fewer S4 embryonic cells injected per host, which was expected since far fewer *piwi-1+* blastomeres are present during S4 versus later stages. The S4 results represent our best efforts to concentrate as many embryo equivalents as possible while minimizing volume of the cell suspension.

We provide scoring data for "no transplant control" data in the text for both sets of transplantation experiments.

We did not run transplantation experiments using adult neoblast enriched fractions as a positive control. We concede that the side by side comparison would be nice to see, though not necessary. There were two reasons for this: 1) We strongly suspected that S8 embryonic cells would rescue since animals at this stage regenerate following amputation (our unpublished observation). The regeneration capacity, coupled with the distribution of *piwi-1+* cells in S8 embryos, suggested strongly to us that upon hatching juvenile worms possess neoblasts. Had we not achieved reproducible rescue results with S8 embryonic donor cells, we certainly would have pursued adult neoblast injection experiments. 2) The published cell transplantation papers used C4 asexual adult animals as donors. Differences in transplanted cell behavior using C4 animals and embryos as donors could arguably be attributed to differences in biotype. While sexually mature adult donor tissue has been shown to rescue in plug graft experiments, we presently don't have a cell sorting protocol for neoblast isolation from sexually mature adults. Our cell sorting protocols are based on DNA content, as well as cell size and morphology; we would expect our neoblast enriched fraction to be contaminated with dividing germline stem cells and transit amplifying germ cells. This would not be insignificant, given that adults possess roughly 100 testes.

Lethally irradiated adults are capable of wound healing, mount an acute transcriptional response to wounding, and transiently reorganize expression domains of key polarity genes along the A-P axis of the fragment. However, these animals never generate a blastema or regenerate new tissue. None of the lethally irradiated, uninjected sexual adult hosts survived long-term, nor did they mount a regenerative response (e.g., head blastema formation) prior to lysing. The most parsimonious explanation for our results is that engrafted, proliferating, donor-derived *piwi-1+* cells contributed differentiating progeny that subsequently mounted the observed regenerative response in rescue animals. We have seen production of post-mitotic, definitive epidermal progenitors in S5 donor cell transplants (*NB.21.11e+* and *AGAT-1+* cells) at 10 dpt (13 dpi); these definitive epidermal progenitors were present in the tail parenchyma in the neighborhood of *piwi-1+* cells. Moreover, *NB.21.11e+* and *AGAT-1+* cells are irreversibly eliminated by lethal irradiation within 5 dpi, suggesting that the cells present in S5 transplanted hosts at 10 dpt (13 dpi) differentiated from donor-derived *piwi-1+* cells. Additional transplant experiments would be required to examine production of differentiating progeny for other lineages. SNPs could be assessed in donor and transplanted hosts after long-term reconstitution; however, this would require using genetically defined lines for embryonic donor cells, which we did not do for these experiments. We agree that using vital membrane dyes to track donor cells would be a good way of assessing donor versus host contribution following transplantation, and will pursue this suggestion in the future.

Reviewer \#3

*\[...\]Abstract:*

*\"Neoblast subpopulations established during embryogenesis persist into adulthood\"*

Subpopulations may not persist as subpopulations, rather continuously generated. Since the renewal capacity of subpopulations is unknown, different wording is suggested.

At present we cannot distinguish between the two possibilities mentioned by reviewer \#3: self-renewal of committed progenitors within the neoblast population (stable, or persistent subpopulations) or the continual re-emergence of committed progenitors from pluripotent stem cell(s) throughout the lifetime of the animal. The concluding sentences of the Abstract now read:

"Neoblast lineages arise as organogenesis begins and are required for construction of all major organ systems during embryogenesis. These subpopulations are continuously generated during adulthood, where they act as agents of tissue homeostasis and regeneration."

We also inserted as sentence in to the final paragraph of the Results text associated with [Figure 6](#fig6){ref-type="fig"}, which addresses this point:

"At present, we cannot distinguish whether lineages perpetually re-emerge due to asymmetric division of pluripotent stem cells, or whether progenitor populations established during embryogenesis are maintained by self-renewal."

Results section:

\"seven morphologically distinct stages (S), S2-S8\" were selected for sequencing. Panels D-F contain embryos that look superficially similar; thus it would be helpful for the authors to further describe at this point in the text the criteria for stage separation in the sequencing experiment (I assume time of development was also a factor?).

Yes, you are correct that a combination of chronology and morphology were used to select samples and define the stages. As stated in the Materials and methods, we rear our animals at 20˚C and collect egg capsules daily. Each collection could theoretically be composed of 0-24 hour old embryos (hours indicating time post egg capsule deposition), but we designate the time of collection as 1 day post-egg capsule deposition and age them out accordingly. The time windows for collection are indicated in [Figure 1B](#fig1){ref-type="fig"}, and the RNA-Seq replicates ([Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}) indicate the time point(s) for each of the stages queried.

The main text now reads:

"*Smed* embryos gestate for approximately two weeks at 20˚C prior to hatching. We generated total RNA replicates from single *Smed* embryos for seven chronologically and/or morphologically distinct stages (S), S2-S8 ([Figure 1B-I](#fig1){ref-type="fig"}); S1 samples (zygotes, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) were not queried by RNA-Sequencing."

\"pairwise comparisons of adjacent time points\"

These aren\'t really \"time points\", since stages overlap in timing. Different wording is suggested.

The wording "time points" was changed to "stages."

Assessment of most statements of data in the text is difficult, because each one requires a goose chase through excel tables, main figures, figure supplements, and online-only figures. Some items called out as figure supplements are not figures but tables with titles different than their figure supplement title. Take subsection "Anarchic, cycling piwi-1+ blastomeres fuel Smed embryonic development", for example; this single sentence refers to 4 panels in 2 main figures, 4 Figure supplements, and 3 supplementary online figures. I tried to find [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} to look at the markers for all known and restricted embryonic cell populations and eventually gave up...

We reorganized and renamed the supplemental data to make it easier for readers to navigate and locate items of interest. Supplemental items are now organized chronologically, as reviewer \#1 suggested. All excel data files are now listed as "Figure X---source data X" files. Supplemental figures are listed as "Figure X ---figure supplement X." SPIM movies are now listed as "Rich Media Files." In addition, the Molecular Fate Mapping Atlas files are now couched under the [Figure 1](#fig1){ref-type="fig"} *subheading, along with the RNA-Seq data. This eliminates a second class of supplemental figure names, which other reviewers also found burdensome. Finally, <https://planosphere.stowers.org>, an online searchable resource, is another venue for examining much of the supplementary data accompanying our manuscript.*

Paragraph four in subsection "Anarchic, cycling piwi-1+ blastomeres fuel Smed embryonic development". The paragraph could use a concluding sentence to clarify message.

Similarly, the point of \"...sample sizes, the optimal θ\' was calculated to be 0.58 +/- 0.33,and was 50-fold more likely to explain the observed trend than a simple normal distribution.\" is not clear.

Reviewer \#1 brought up the same points, and we revised the main text and figure legends to minimize the technical detail and bring forth the main conclusions. The revised text is included earlier in the rebuttal, under the comments to reviewer \#1.

Last paragraph of the subsection: restriction of cell cycle activity to piwi+ cells in adults should reference the piwi-1 2005 paper and could also reference Wagner 2011, which had further analysis of this marker for all dividing cells.

We apologize for this oversight and added both references to this passage.

Figure 4---figure supplement 2Y12 data is interesting, but only S4 staining is apparent. If it is not present in piwi+ cells at earlier stages this merits display. The chromatoid body presence could also be considered for a main figure.

Y12 staining was only performed on S4 and S5 embryos. The manuscript was revised as follows:

"Y12 antibodies, which specifically label chromatoid bodies in adult neoblasts {Rouhana, 2012 \#482}, stained *piwi-1+* blastomeres during S4-S5 ([Figure 4---figure supplement 1G](#fig4s1){ref-type="fig"}, Rich Media File 10)."

Subsection "Early embryo enriched transcripts expressed throughout piwi-1+ blastomeres are downregulated as organogenesis begins". Naming clusters \"6\" \"5\" can be deciphered from examination from the figure, but is not immediately clear what these are when reading the text. i.e., individual of the multiple clusters of S2-S4-enriched txts that showed downregulation at S5 and thereafter.

We altered this paragraph significantly to clarify what we mean by the term "EEE transcripts." Some of the details regarding expression trends in clusters 5, 6 and 8 were moved the [Figure 5A](#fig5){ref-type="fig"} legend.

The main text now reads:

"Hierarchical clustering of S2-S4 enriched transcripts using scaled RPKM values identified 1048 sequences in clusters 5, 6 and 8 that were downregulated by S5 and remained lowly expressed through S8; these sequences are referred to as early embryo enriched (EEE) transcripts ([Figure 5A](#fig5){ref-type="fig"}, [Figure 5---source data 1](#SD11-data){ref-type="supplementary-material"}). EEE transcripts were likely expressed in blastomeres and/or temporary embryonic tissues, since 98% of the sequences had average expression values at least 5-fold greater in S2 embryos versus Y ([Figure 5---source data 1](#SD11-data){ref-type="supplementary-material"}). Most EEE transcripts were expressed at low levels in intact adults regardless of biotype: average RPKM values less than 1.0 were recorded for 65% and 59% of the EEE transcripts in C4 or SX, respectively ([Figure 5---source data 1](#SD11-data){ref-type="supplementary-material"})."

The [Figure 5A](#fig5){ref-type="fig"} legend now reads:

**"**Hierarchical clustering of S2-S4 enriched transcripts (n=1756) using scaled RPKM data. Left: Heat map. Y: yolk. Colored bars (left) denote clusters 5, 6 and 8 containing early embryo enriched (EEE) transcripts. Cluster 5 sequences (blue, n=413) were expressed at roughly equivalent levels during S2 and S3, with 66% (n=275) transcripts showing 5-fold or greater declines in average expression values between S3 and S5. Cluster 6 sequences (red, n=523) exhibited maximal expression during S2, and average expression levels declined more than 5-fold between S2 and S4 for 81% (n=426) of these transcripts. Cluster 8 sequences (green, n=112) showed peak expression during S4, with 52% (n=60) of the transcripts showing 5-fold or greater declines in average expression values by S5. Right: Normalized expression trends for EEE transcripts in Clusters 5 (blue), 6 (red) and 8 (green) plotted as a function of developmental time. Median 50% of transcripts based on expression maxima are plotted."

The third paragraph in this section presents analysis of expression of the interesting EEE genes. However, the main messages/synthesis is hard to decipher because of the distracting links out to disparate files/figure locations. The narrative/text feels beholden to a set of files and figures as opposed to the other way around.

We rewrote the section to more clearly articulate our main points. In addition, moved the summary of the WISH expression screen from [Figure 5---source data 1](#SD11-data){ref-type="supplementary-material"} (formerly [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}) to a separate file, [Figure 5---source data 3](#SD13-data){ref-type="supplementary-material"}. The rewritten text is as follows:

"To determine which cell types express EEE transcripts, and to examine spatiotemporal changes in EEE transcript expression, colorimetric WISH was performed on S2-S8 embryos and intact C4 adults ([Figure 5---source data 3](#SD13-data){ref-type="supplementary-material"}). Some EEE transcripts were expressed exclusively in differentiated temporary embryonic tissues. *VAL-like, MPEG1-like-1, MPEG1-like-2,* and *netrin-like* were solely expressed in the temporary embryonic pharynx until S6, while *gelsolin-like* and *4XLIM-like* were expressed in both the primitive ectoderm and temporary embryonic pharynx during S3-S4 ([Figure 5---source data 3](#SD13-data){ref-type="supplementary-material"}, [Figure 1 ---figure supplements 11D-E](#fig1s11){ref-type="fig"}, [12C-G](#fig1s12){ref-type="fig"}). Expression of these EEE transcripts is likely under zygotic control, occurring during or after the cell fate decisions to downregulate *piwi-1,* exit the cell cycle and differentiate.

Most EEE transcripts queried by WISH (n=15, 75% assayed) were expressed in both undifferentiated blastomeres and temporary embryonic tissue(s) during S3-S4 ([Figure 5B-E](#fig5){ref-type="fig"}, [Figure 5--- source data 3](#SD13-data){ref-type="supplementary-material"}). Some of these transcripts may be maternally deposited, albeit we cannot ascertain the relative contribution(s) of maternal and zygotic expression from our RNA-Sequencing data. Expression of these EEE transcripts diminished greatly by S5, with moderate and lowly expressed EEE transcripts becoming undetectable; specific expression of robustly expressed transcripts sometimes persisted until S6 ([Figure 5B-E](#fig5){ref-type="fig"}, [Figure 5---source data 3](#SD13-data){ref-type="supplementary-material"}). Consistent with the RNA-Seq and Nanostring nCounter results, EEE transcript expression was not detected by colorimetric WISH in S7, S8 embryos or C4 adults ([Figure 5B-E](#fig5){ref-type="fig"}, [Figure 5 -- source data 3](#SD13-data){ref-type="supplementary-material"}). Fluorescent double WISH performed with riboprobes complementary to *piwi-1* and the EEE transcripts *tct-like, BTF3-like, DDX5-like* and *eIF4a-like* revealed coincident expression throughout the S4 blastomere compartment ([Figure 5F-I](#fig5){ref-type="fig"}). Intriguingly, EEE transcript expression often decayed quicker in differentiated cells than undifferentiated blastomeres, raising the possibility that regulation of EEE transcription and/or transcript stability may vary by cell type. While robust expression of many EEE transcripts was detected in blastomeres during S3-S4, EEE transcript expression in temporary embryonic tissues was present during S3 and drastically diminished by S4 ([Figure 5B-E](#fig5){ref-type="fig"}, [Figure 5---source data 3](#SD13-data){ref-type="supplementary-material"}).

EEE transcripts expressed throughout the undifferentiated *piwi-1+* blastomere population in S3-S4 embryos are downregulated as definitive organogenesis begins during S5. These transcripts likely represent a key temporal shift in the expression profile of *piwi-1+* cells during embryogenesis. Moreover, EEE transcript expression provides a molecular metric to distinguish *piwi-1+* blastomeres from adult neoblasts."

More discussion of the EEE genes that are expressed broadly in the embryo would be of interest. What types of genes were discovered?

We have validated expression of a relatively modest cohort of EEE transcripts by WISH, and will do more extensive work to rigorously identify homologs, validate expression of additional candidates and ultimately will devise RNAi knock-down methodology to query function of these genes during S2-S4. The EEE transcripts that were specifically expressed in temporary embryonic tissues clustered with those that showed pan-embryonic expression during S3, followed by blastomere-specific expression during S4; that may confound attempts to hypothesize much based on the annotations alone. Roughly a third of the EEE transcripts have no BLASTx hit versus the NR or Swiss-Prot databases, and are considered novel; we have done little to pursue these candidates. Of the candidates that have BLASTx-based annotations, many appear to be involved in translational control and proteostasis; these candidates superficially appear similar to the types of maternally deposited transcripts present in other organisms, but of course we cannot confirm or refute that connection at this point. The annotated lists are provided in [Figure 5---source data 1](#SD11-data){ref-type="supplementary-material"}.

Reviewer \#4

\[...\]Specific comments:

The Introduction is long and detailed on many aspects of neoblast biology, but at the same time unclear and lacking in other aspects. Generally, I am often not sure whether the authors talk about facts known from previous studies, or are already highlighting the findings to be reported in this paper.

*Suggestion: shorten the intro by at least 50%. After (in a briefer format than now) summarizing known functions and types of neoblasts in adults/regeneration, summarize literature (as far as it exists) regarding*

*-embryogenesis in planarians (see below; the statements about embryogenesis that are now found in section 2 of the Results should be in the Introduction)*

-specifically, what is said in the literature where/when do neoblasts first appear in embryos (there will probably not be a lot of published information; one example is Ramachandra et al., 1999, on embryonic BrdU -positive presumed neoblasts in an Acoel).

-proliferation, migration, differentiation of neoblasts during embryonic period.

The Introduction was shortened in accordance with comments from reviewers \#1, 2 and 4. The lengthy discussion of our results was removed from the Introduction. Instead, we highlight our main conclusions and conceptual advances at the end of the revised Introduction. Information pertaining to neoblasts -- molecular and functional definitions, functions, subclasses, and roles during adulthood -- were condensed and reorganized, as suggested by reviewer \#4.

In the interest of making the manuscript more accessible to a general audience, we added two new paragraphs to the start of the Results section which introduce some of the essential concepts and terminology for Triclad embryos (e.g., direct developer, ectolecithal embryo, dispersed cleavage, temporary embryonic tissues, definitive organs).

Results

Section 1: surveys molecular staging; stages themselves described in supplementary table and figures. This is a useful and important work of reference for the planarian developmental field.

Please highlight in the text:

*-what in terms of morphogenesis and organogenesis is novel compared to the previous embryological study of Schmidtea polychroa (Cardona et al)*

*-how do stages utilized here (1-8) differ from the 8 previously introduced ones*

We are happy to comment on similarities and distinctions between our staging series and the published staging series for *S. polychroa (Spol).* However, we do not expound on these points in the Results section because they will likely appeal to specialists and not the broader *eLife* readership. Note that it is difficult to directly compare developmental timing with those of the 8 stages presented in the Cardona et al. 2005 publication because the *Spol* animals were reared at 17˚C and had a gestation time of around 20 days. To confound matters further, the Romero lab later published another *Spol* staging series for animals reared at 20˚C (Martin-Duran et al. 2010), in which only 7 stages are articulated.

*Smed* Stage 1/*Spol* Stage 1 (Cardona et al. 2005)/Not present in (Martin-Duran et al. 2010): We do not have a molecular signature for Stage1 and we have not looked at the zygote or first cell divisions in detail. Commenting further at this point is difficult. In addition, *Spol* animals are parthenogenic while *Smed* reproduce sexually, so gametogenesis, egg activation and zygote formation likely differ between the species.

*Smed* Stage 2/*Spol* Stage 2 (Cardona et al. 2005)/Stage 1(Martin-Duran et al. 2010): Both *Smed* and *Spol* embryos are ectolecithal developers, have blastomeres that undergo dispersed cleavage and form spheres. We believe asymmetries are present within the blastomere population during S2, but disagree with the "Type 1" and "Type 2" blastomere designations presented in Cardona et al. 2005, and which were eventually disavowed in later *Spol* publications. We cannot comment on the molecular mechanisms implicated in sphere formation at present.

*Smed* Stages 3+4/*Spol* Stage 3(Cardona et al. 2005)/ *Spol* Stage 2+3 (Martin-Duran et al. 2010): Our molecular profiling data supports our designation for two separate stages. *Smed* Stage 3 is likely most analogous to *Spol* Stage 2 (Martin-Duran et al. 2010), while *Smed* Stage 4 is likely most analogous to *Spol* Stage 3 (Martin-Duran et al. 2010).

*Smed* Stage 5/*Spol* Stage 4-5(Cardona et al. 2005)/*Spol* Stage 4 (Martin-Duran et al. 2010): Gut development is clearly underway during Stage 5, but since these gastrodermal cells express novel embryonic markers it is difficult to say without further analysis whether this is a temporary or definitive tissue. Mature gut progenitors arise at this stage, but the gastrodermal cells lining the intestinal cavity do not express these markers. While we agree that more blastomeres, and hence more mitotic cells are present during S5 than earlier stages, our analysis of the mitotic index for the blastomere compartment suggests that the S3-S5 *Smed* blastomeres divide at a constant rate, arguing gainst the "mitotic burst" phenomenon described in *Spol* references.

*Smed* Stage 6-8/*Spol* Stages 6-8 (Cardona et al. 2005): these stages are superficially similar, though distinctions in timing and morphology may be present for different definitive organ systems mentioned.

*Smed* Stage 6-7/Stage 5 (Martin-Duran et al. 2010): Elongation may occur, on average, much sooner in *Spol* embryos than *Smed* embryos.

*Smed* Stage 7-8/Stage 7 (Martin-Duran et al. 2010): Definitive organ development and maturation may occur, on average, much sooner in *Spol* embryos than *Smed* embryos.

It would certainly be possible to conduct similar expression profiling studies in *Spol* and/or other freshwater planarian embryos, and/or to examine spatiotemporal changes in expression patterns during embryogenesis for homologs of the markers we present in this publication. Comparative analysis of gene function during embryogenesis would also be required for informed comment on many of these issues.

-what does molecular profiling add to defining stages (clearer temporal distinction?..)

The molecular profiling data suggests that the genetic regulatory networks and molecular mechanisms governing *Smed* embryogenesis are robust, and likely temporally much more precise than was anticipated from previous studies of freshwater flatworm embryogenesis. Our RNA-Sequencing data underscores the profound developmental transition between Stages 4 and 5, one that is not readily apparent by changes in morphology alone. We were also able to identify new classes of embryo enriched transcripts which were not anticipated from previous studies. Moreover, the gene expression signatures for each stage provide a wealth of candidates for novel tissue and/or stage specific markers and putative genetic regulators whose function(s) will be assessed in future studies.

*Section 2 -- "Anarchic, cycling piwi-1+ blastomeres fuel Smed embryonic development"*

The section describes the expression pattern of piwi, and concludes that the gene is restricted to undifferentiated cells. The text is very difficult to read. Different types of information are intermingled. For example, paragraph two summarizes a result known from the literature. Talks about general expression patterns of non-specified transcripts, documented only in the supplementary material, in differentiating cells. later in the paragraph you speak to the point: piwi is expressed in undifferentiated cells in the bodywall at the S3 stage. But how does the pan-nuclear marker EF1a-like 1 show that, since this marker appears to be expressed in all cells (including the piwi-positive ones)?

The data presented in [Figure 2](#fig2){ref-type="fig"} was reorganized with *EF1a-like-1* expression depicted in [Figure 2A-B](#fig2){ref-type="fig"}, and *piwi-1* expression depicted thereafter. The text was revised to clarify some of the important points brought up by reviewers \#1 and \#4. The first paragraph of the section, "An anarchic, cycling *piwi-1+* blastomeres fuel *Smed* embryonic development," describes the *EF1a-like-1* expression in S2 and S3 embryos, and includes detailed descriptions of embryonic cell types and architecture. *EF1a-like-1* is a pan-embryonic marker, meaning that it is expressed in differentiated temporary embryonic tissues (the primitive ectoderm, the temporary embryonic pharynx, the primitive gut) and the undifferentiated blastomeres located in the embryonic wall (the parenchymal space between the primitive ectoderm and endoderm) of S3 embryos. *EF1a-like-1* is not expressed in yolk cells. Yolk cells are present in the embryonic wall along with the blastomeres; these cells have very small, condensed sytox green+ nuclei. Ingested yolk is also present in the primitive gut cavity. Blastomere nuclei are larger, with diffuse sytox green signal (likely due to the decondensed nature of the chromatin), are easily distinguished from yolk cell nuclei in the embryonic wall. In addition, the blastomere nuclei are readily distinguished from primitive ectodermal nuclei by sytox green staining; latter are stretched and sit at the surface of the sphere. We are confident that the combination of *EF1a-like-1* and nuclear staining makes allows for unambiguous identification of undifferentiated blastomeres in the embryonic wall of S3 embryos. *Piwi-1* expression was always restricted to, and expressed throughout, the undifferentiated blastomere compartment of S3 embryos in *EF1a-like-1, piwi-1* costaining experiments. Quantification is provided in the [Figure 2E](#fig2){ref-type="fig"} legend.

The final sentences again talk about findings from the previous literature.

I suggest to remove all references to the previous literature from this (Results) section; put them in the Introduction, and in the Results focus on where exactly piwi is expressed. Specifically:

Paragraphs 1-2

-DAPI shows large number of labeled dots: are these all nuclei of blastomeres ([Figure 2A, C](#fig2){ref-type="fig"})?

-if so, only a small subset of blastomeres expresses piwi (2A): how would one characterize distribution? Clustered, around embryonic pharynx?

No, all of the nuclei are NOT blastomeres in the former [Figures 2A and 2C](#fig2){ref-type="fig"} (now 2D and 2B, respectively). Yolk cells are abundant but do not express either *EF1a-like-1* or *piwi-1.* Please refer to the previous paragraph regarding the *EF1a-like-1,* sytox green costaining results.

The distribution of blastomeres in S3-S4 embryos varies widely, as described in [Figure 2H](#fig2){ref-type="fig"}. At present we cannot comment on the distribution of the blastomeres during S2 as the embryos undergo sphere formation; that would require costaining with additional markers specific for the temporary embryonic tissues.

-Paragraph 2: sounds like piwi is downregulated in many cells. What is shown ([Figure 2A](#fig2){ref-type="fig"}) is that from beginning, piwi is expressed in only few blastomeres (if DAPI really reflects all nuclei). Is there an earlier stage with many more piwi+ cells?

*-the pattern and dynamics of piwi in undifferentiated cells (\"blastomeres\") remains a bit vague. Is the pattern the following: stage 1, before embryonic transient cells differentiate: all cells express piwistage 2/3: as embryonic cells differentiate, they lose piwi; ALL other cells retain itlater stages: as adult cells become postmitotic, they lose piwi; ALL other cells retain it*

I don\'t think this is what happens. But the authors do not make it clear in text and figures what exactly happens. I assume that only a small subset of undifferentiated cells express piwi. I understand that these are distributed. This information needs to be settled; it is one of the crucial pieces of data required in subsequent sections (see comments below).

We show that *piwi-1* mRNA is maternally deposited in oocytes ([Figure 2C](#fig2){ref-type="fig"}, revised manuscript), and that *piwi-1+* blastomeres undergo dispersed cleavage during S2, prior to sphere formation ([Figure 2D](#fig2){ref-type="fig"}, revised manuscript). As noted previously, nuclear dyes mark both blastomere and yolk cell nuclei. Our data suggests that *piwi-1* is expressed in the zygote and its descendants, the blastomeres, during S2. During sphere formation, asymmetries in the *piwi-1+* blastomere population become evident: some blastomeres differentiate into temporary embryonic tissues, and these cells down-regulate *piwi-1* and exit the cell cycle. We do not know when asymmetries within the *piwi-1+* blastomeres develop during S2 and would like to explore this in the future. However, we never detect expression of *piwi-1* ([Figure 2G](#fig2){ref-type="fig"}, revised manuscript) or the cell cycle markers *PCNA* or *RNRM2-2* ([Figure 3A-B](#fig3){ref-type="fig"}, revised manuscript) in differentiated tissues of S2 or S3 embryos (compare to the expression pattern for *EF1a-like-1* in [Figure 2A-B](#fig2){ref-type="fig"}, revised manuscript). During S3 and thereafter, *piwi-1* expression is restricted to undifferentiated cells. We agree with reviewer \#4 that clear communication of these points is critical, and revised the text associated with [Figure 2C-G](#fig2){ref-type="fig"} (revised manuscript) as follows:

*"piwi-1+* cells were present throughout embryogenesis. *piwi-1* expression was detected in oocytes ([Figure 2C](#fig2){ref-type="fig"}), suggesting that zygotes contain *piwi-1* mRNA. Zygote-derived blastomeres undergoing dispersed cleavage among yolk cells during S2 also expressed *piwi-1* ([Figure 2D](#fig2){ref-type="fig"}). Costaining with *piwi-1* riboprobes and antibodies raised against the G2-M phase mitotic marker H3S10p showed that *piwi-1+* blastomeres divide asynchronously during S2 ([Figure 2D](#fig2){ref-type="fig"}).

As spheres form during S2, some blastomeres downregulate *piwi-1* expression and differentiate into temporary embryonic cell types. *piwi-1* expression was restricted to, and expressed throughout, the undifferentiated blastomere population in S3 embryos, as demonstrated by double fluorescent WISH with *EF1a-like-1* and *piwi-1* riboprobes([Figure 2E](#fig2){ref-type="fig"}, Rich Media File 2). *piwi-1+* blastomeres were always located in the embryonic wall, sandwiched between the primitive ectoderm and endoderm ([Figure 2F](#fig2){ref-type="fig"}). *piwi-1* expression was never detected in primitive ectodermal cells, the embryonic pharynx or primitive gut cells ([Figure 2E, G](#fig2){ref-type="fig"}). During S3-S5, *piwi-1+* cell number clearly increased, effectively blanketing the sphere ([Figure 2G](#fig2){ref-type="fig"}). As definitive gut development proceeded during S6-S8, *piwi-1+* cells occupied the parenchyma between the developing gut branches ([Figure 2G](#fig2){ref-type="fig"}). Notably, *piwi-1+* cells were not detected in the definitive pharynx, and the compartment receded from the anterior margin as head structures developed ([Figure 2G](#fig2){ref-type="fig"}). By S8, the spatial distribution of *piwi-1+* cells was indistinguishable from that of the adult neoblast compartment ([Figure 2G](#fig2){ref-type="fig"})."

*Section 3 reports that genes sets known to be associated with adult neoblasts are also expressed in the embryo. This is an important finding. The main question is:*

*-are these genes, in the embryo (e.g., S4, S5, S6), restricted to piwi+ cells?*

*-are they restricted to ALL undifferentiated cells (assuming that not all undifferentiated cells are piwi+; see my questions/comments above)*

*-are they also expressed in cells that stop dividing and differentiate?*

I was not able to find a clear answer to these questions in the text.

We show colocalization analysis for *piwi-1* and several adult asexual neoblast-enriched genes, including *piwi-2, piwi-3, bruli-1* and *tud-1* in S3-S5 embryos ([Figure 4F-I](#fig4){ref-type="fig"}). The staining patterns are coincident at these stages, meaning that all *piwi-1+* cells express these markers (and vice versa). These data suggest that all undifferentiated cells express a similar complement of nuage genes in S3-S5 embryos: they are pan-blastomere markers at early stages, just as they are expressed throughout the neoblast population in adulthood. The numbers in the lower right corner of the merged images display the percent colocalization with respect to both populations scored (see [Figure 4F-I](#fig4){ref-type="fig"} legend); very few single positive cells were observed. We have not performed colocalization analysis and quantification on S6 and older embryos, but would predict to see virtually all *piwi-1+* cells at later stages expressing these markers, as do adult neoblasts.

Some differentiating and/or terminally differentiated cells may retain expression of some of these markers. For example, *bruli-1* expression was detected in the four neurons innervating the temporary embryonic pharynx ([Figure 4E](#fig4){ref-type="fig"}), and may be expressed in the brain and potentially other neural tissues in late stage embryos, as in adults. Similarly, *piwi-2* expression was frequently seen in the S3 temporary embryonic pharynx ([Figure 4B](#fig4){ref-type="fig"}), and may also be expressed in neural tissues in late stage embryos, as seen in adults. In the future, RNA-Seq on cycling cells versus differentiated cells or whole embryos (WT or irradiated) may yield a global view of how enriched or exclusive expression of these genes are to the blastomere/neoblast compartment.

Section 4 Early embryonic genes (EEE)

I don\'t understand the message of this section. One reason for confusion arises right at the beginning:

\- in the opening lines the authors talk about \"S2-S4 enriched transcripts expressed throughout the piwi blastomere population\".

\- then the authors introduce the 1048 EEE genes: are these the same as above (i.e., they are expressed in the piwi blastomere population)?

The 1048 EEE transcripts are a subset of the 1756 S2-S4 enriched transcripts that were clustered in [Figure 5A](#fig5){ref-type="fig"}. Specifically, these 1048 transcripts comprise clusters 5, 6 and 8. Details regarding the expression profiles and BLASTx-based annotation of the EEE transcripts are found in [Figure 5---source data 1](#SD11-data){ref-type="supplementary-material"} (formerly [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

For clarification, we rewrote the first paragraph of this section and moved some of the detailed description of the cluster 5, 6 and 8 expression trends to the [Figure 5A](#fig5){ref-type="fig"} legend. The revised text for both the manuscript and figure legend are detailed in a response to reviewer \#3, who also brought up this point.

\- because, if they are: why do piwi (undifferentiated) blastomeres and differentiated (transient embryonic cells) express the same set of genes? I thought from the previous sections (and on general grounds) that as cells become postmitotic and differentiate, they switch on different genetic programs.

In response to comments from reviewer \#3, we rewrote the section detailing the WISH screen and costaining experiments described in [Figure 5B-I](#fig5){ref-type="fig"}; please see the previous section for the revised text. Maternal deposition of some EEE transcripts may explain why undifferentiated blastomeres and differentiated temporary embryonic cell types in S3 embryos co-express some EEE transcripts. However, we note that expression of these EEE transcript diminishes quicker in the temporary embryonic tissues than in the blastomeres. Differential transcript stability, relative contributions of maternal load and zygotic transcription, and different modes of maternal mRNA degradation may all be at play and could be investigated in the future. We also note that some EEE transcripts do appear to be expressed exclusively in differentiated cell types, like the temporary embryonic pharynx and the primitive ectoderm. This is consistent with the idea that cells turn on different genetic programs as they differentiate, and suggests that these EEE transcripts are transcribed zygotically, during or after the cell fate decision to downreguate piwi-1, exit the cell cycle and differentiate.

Section 5

It is shown that gene sets associated with specific differentiated cell types are upregulated around stage 5, which is important, but expected, since it confirms the observation that cells differentiate (structurally) at this stage.

The main claim of the heading of this section (that progenitors of specific cell types arise WIHIN the piwi-positive population) needs to be demonstrated, and/or described more clearly (see questions to section 2 above)

Great care was taken to articulate each point critical to our model of how the diversity of lineages required for organogenesis are born during *Smed* embryogenesis. Moreover, our results immediately suggest why gastrulation is dispensible for freshwater planarian embryos. While many details remain to be worked out in the future, we are energized by paradigm-challenging ramifications of our work. We made very modest changes to the text for this section, as we contend that reviewer \#4's difficulty understanding the conclusions were rooted in not in our writing, but her/his confusion about ectolecithal development and whether *piwi-1* was expressed throughout the undifferented blastomere population (see comments related to [Figure 2](#fig2){ref-type="fig"}).

Section 6

*Cell suspensions derived from embryos at different stages (S5-S8) were injected into irradiated adults, and were able to rescue them. This is also an important experiment. A puzzling finding was that cells from S5 embryos were unable to rescue. Is it possible that S5 embryos did not have a high enough density of piwi+ cells to do the job? Is it possible to get a value for the number of piwi+ cells present in an aliquot of the cell suspension from different stage embryos?*

We show that comparable numbers of *piwi-1+* cells were introduced per host for S5 and later stages (see Revised [Figure 7C](#fig7){ref-type="fig"}, quantification for the number of *piwi-1+* cells per host at 1 hour post-transplant). This data was present in the supplemental material in our initial submission, and was moved to a main figure due to its importance for our conclusion regarding stage-dependent differences in donor cell activity.
